Allied Gold Corporation

AAUC.TO Q2 2026

Reported: 2026-08-08

Allied Gold’s shares jumped 10.9% post-earnings, driven by operational beats at key mines and progressing growth projects that bolster confidence in the company’s production trajectory and cost reduction initiatives.

Key takeaways

Q2 production totaled just over 97,000 ounces; H1 production reached approximately 193,000 ounces, with full-year guidance on track from existing operations.
Sadiola’s production expected to rise in H2 due to increased feed grade and throughput; ongoing cost reduction efforts include transitioning from diesel to solar power.
Bonikro exceeded first-half production plans with higher grades and throughput, marking successful progression past the waste removal phase.
Agbaou production steady with improved costs; proven and probable reserves expanded by 60%, supporting extended mine life and increased annual production expectations (from 180,000 oz to 200,000 oz).
Kurmuk mine in Ethiopia in commissioning phase, expected to begin production this quarter, adding to near-term growth prospects.

View recap

Axcelis Technologies, Inc.

ACLS Q2 2026

Reported: 2026-08-08

Axcelis Technologies shares rose modestly by 2.6% post-earnings as the company posted revenue and EPS slightly above expectations; however, the mixed market signals suggest investor caution given the anticipated sequential memory decline and slower order growth in some segments.

Key takeaways

Q2 revenue totaled $215 million with EPS of $1.06, both modestly exceeding company expectations.
Sequential growth in systems revenue was supported by power and general mature markets but was partially offset by an expected moderation in memory sales due to fab space timing.
Bookings showed only slight growth, driven by general mature and power markets, with the book-to-bill ratio near 1 over the past three quarters, indicating stable but not accelerating demand.
Silicon carbide revenue declined sequentially due to shipment timing, though bookings improved and new customer wins in China were noted.
Advanced logic and memory engagements remain strong, including orders for 2-nanometer and high-current systems, but memory sales were down sequentially as anticipated given fab availability constraints.

View recap

Koninklijke Ahold Delhaize N.V.

AD.AS Q2 2026

Reported: 2026-08-08

Shares declined 1.2% following the Q2 report as investors appeared cautious despite stable execution and reiterated guidance, likely reflecting concerns over moderating growth dynamics and limited margin expansion amid ongoing investment initiatives.

Key takeaways

Own brand penetration reached over 40%, up 0.7 percentage points this quarter, supported by 200 new private label items particularly in the U.S.
Focused price investments were made in key markets, including broad price reductions at Stop & Shop and value pricing initiatives at Hannaford, Albert Heijn, and Serbia’s Maxi.
The company continued investing in AI and technology, approving over 120 use cases aimed at improving merchandising, sourcing, marketing, and operations efficiency.
Management reiterated full-year guidance despite a "softer macroeconomic environment," signaling no upward revision amid competitive pressures.
No explicit details on margin trends were provided, but ongoing investments and competitive price actions may constrain near-term margin expansion.

View recap

Akamai Technologies, Inc.

AKAM Q2 2026

Reported: 2026-08-08

Akamai's shares fell 9.6% following the earnings release, driven by investor concerns over cautious guidance and potential margin pressure despite strong AI-related bookings and solid security revenue growth.

Key takeaways

Signed over $2.8 billion in multiyear cloud infrastructure commitments so far in 2026, including a notable $600 million deal from a U.S. technology company.
Anticipates revenue growth accelerating into the low teens in 2027, reflecting confidence in AI-driven demand but signaling a tempered near-term outlook.
Security segment grew 10% year-over-year, supported by continued demand for web application firewall, API security, and segmentation solutions, including a $14 million upgrade from a top bank and a $20 million telco renewal.
Highlighted strategic partnerships and positioning as a foundational player in AI infrastructure and security, including selection in WWT’s AI Readiness Model (ARMOR) for Operational Resilience.
Market reaction suggests investors remain wary of potential margin compression and the sustainability of growth given cautious commentary and no explicit margin or upside guidance.

View recap

Albemarle Corporation

ALB Q2 2026

Reported: 2026-08-08

Albemarle's shares rose 10.3% after the company delivered significantly better-than-expected pricing power and margin expansion in both Energy Storage and Specialties segments, driving robust top-line and profitability gains alongside strong cash conversion.

Key takeaways

Q2 net sales increased 31% year-over-year to $1.7 billion, led by a 73% price increase in Energy Storage and an 11% rise in Specialties pricing.
Adjusted EBITDA more than doubled to $858 million with an enterprise margin expanding to 49%.
Energy Storage adjusted EBITDA surged 229%, supported by an average realized lithium carbonate price of ~$20/kg LCE despite a 15% pricing lag due to spodumene sales and contract structures.
Specialties segment sales rose 20% with adjusted EBITDA up 61%; EBITDA margin improved 700 basis points driven by favorable bromine pricing and product mix.
Free cash flow generation was strong at $638 million with operating cash conversion over 80%, underscoring disciplined cost management and capital efficiency.

View recap

APA Corporation

APA Q2 2026

Reported: 2026-08-08

APA Corporation’s shares rose 8.6% following better-than-expected operational efficiency and a raised oil production outlook, driven primarily by reduced capital intensity in the Permian and sustained production in Egypt.

Key takeaways

Full year Permian oil production guidance was raised to 123 thousand barrels per day, up from 120 thousand barrels, alongside a reduction in rig count from 8 to 4.
Capital expenditure guidance remained flat at $1.3 billion despite inflationary headwinds, reflecting significant improvements in drilling and completions efficiency.
Egypt production met guidance, supported by higher gross volumes and a revised pricing agreement enhancing gas portfolio value.
Annualized run rate cost savings target increased to $500 million, up from the initial $450 million target at the start of the year.
APA continues to prioritize balance sheet strength and shareholder returns, targeting $3 billion net debt and maintaining at least 60% of free cash flow returned to shareholders in 2026.

View recap

Apple Inc.

APC Q2 2026

Reported: 2026-08-08

ARKO Petroleum’s stock declined 2.0% following its Q2 2026 earnings release, reflecting investor caution despite the announcement of a transformative acquisition; concerns likely stem from the expected leverage increase and integration risks, with no indication that the quarter's core operating results overcame these worries.

Key takeaways

Announced acquisition of U.S. Petroleum Partners, adding ~280 million gallons of annual wholesale fuel volume (14% increase) and expanding retail locations by 400 to over 2,500.
Acquisition includes two fuel storage terminals on the Buckeye Pipeline and a fleet of trucks, adding vertical integration and new fee-based revenue streams.
Transaction expected to be accretive, adding approximately $30 million in annual adjusted EBITDA post-closing, with synergies targeted for 2027 and beyond.
Pro forma net debt to adjusted EBITDA ratio expected to rise to 3.0x–3.5x from 2.2x, still within target range but reflects leverage increase and potential funding risks.
No detailed disclosure of Q2 operational or margin trends in the available transcript, limiting clarity on ongoing business momentum or deceleration.

View recap

Aptiv PLC

APTV Q2 2026

Reported: 2026-08-08

Aptiv’s shares gained 5.4% post-earnings, driven by better-than-expected momentum in new business awards and non-automotive revenue growth despite a cautious near-term outlook due to ongoing demand pressures in the automotive market, particularly in China.

Key takeaways

Delivered 2% revenue growth and 10 bps EBITDA margin expansion in Q2.
Non-automotive segment reported double-digit revenue growth, benefiting from diversified end markets and new program wins.
Secured $5 billion in new business awards in Q2, with year-to-date total reaching $10 billion toward a $20 billion full year target.
Automotive market faced headwinds from prolonged sales weakness in China and reduced production schedules by local OEMs and luxury European exporters.
Repurchased $250 million in shares during Q2, totaling $325 million year-to-date, with plans to continue share buybacks exceeding $600 million in 2026.

View recap

Arcturus Therapeutics Holdings Inc.

ARCT Q2 2026

Reported: 2026-08-08

Arcturus shares surged 18.4% as the market rewarded the regained global rights to its validated sa-mRNA vaccine platform and KOSTAIVE COVID vaccine, along with a $12 million upfront payment and removal of $16 million in liabilities. This strategic move clearly outshined ongoing development progress in rare disease programs that remain largely in clinical stages.

Key takeaways

Regained full global rights to KOSTAIVE COVID vaccine and broader infectious disease sa-mRNA platform, providing strategic control and commercial flexibility.
Received $12 million cash payment from CSL Seqirus and eliminated approximately $16 million in related liabilities, positively impacting the balance sheet.
Ongoing Phase II clinical studies for ARCT-032 (cystic fibrosis) and ARCT-810 (OTC deficiency) advancing as planned, with Phase II enrollment completed for ARCT-810; data readouts expected later this year.
Expansion of ARCT-032 trial enrollment into Israel and Turkey to access higher prevalence patient populations with null CF mutations, potentially accelerating recruitment.
No updates provided on financial results or near-term commercial revenue streams beyond the vaccine portfolio transaction.

View recap

Arhaus Inc. Class A Common Stock

ARHS Q2 2026

Reported: 2026-08-08

Arhaus shares gained 16.6% following a quarter that delivered record net revenue and a notable 12.5% increase in comparable written sales, driven by broad-based demand and solid execution across all channels.

Key takeaways

Reported net revenue of $385 million, surpassing the high end of guidance.
Comparable written sales rose 12.5% in Q2, lifting year-to-date comparable written sales to 2.8%.
Strength across core customers, interior design, and trade channels, with evidence of larger, higher-value projects and no indication of customer trade-down.
Inventory availability improved, supporting higher conversion rates and better client experience ahead of the fall selling season.
Continued investment in product innovation, showroom expansion, and relationship building with design professionals bolsters long-term growth prospects.

View recap

AerSale Corporation

ASLE Q2 2026

Reported: 2026-08-08

AerSale’s shares dropped 8.4% post-earnings as investors reacted negatively to decelerating revenue driven by lower USM sales, margin pressure from ramp-up costs at new facilities, and slower-than-expected growth in maintenance volume.

Key takeaways

Q2 revenue declined to $70.9 million, with adjusted EBITDA falling to $2.2 million, both below prior year levels.
Absence of flight equipment sales masked operational improvements; USM revenue decreased due to reduced feedstock purchases amid a competitive market.
TechOps revenue rose nearly 9%, led by CRJ700/900 maintenance ramp-up and increased storage activity, but segment margins contracted due to start-up costs and lower accessory shop throughput.
Margin compression largely stems from investments to scale new facilities in Goodyear and Millington, as well as additional labor held for maintenance related to the Spirit shutdown.
Leasing gains partly offset weakness: leasing revenue grew approximately 50% year-over-year to $12.4 million, with a growing freighter and engine portfolio supporting recurring revenue growth.

View recap

Allegheny Technologies Incorporated

ATI Q2 2026

Reported: 2026-08-08

The 11.1% stock rally underscores investor approval of ATI’s significant beat on adjusted EBITDA and margin expansion, driven by the transformed AA&S segment and strong backlog visibility. The upgrade to full-year guidance across all key metrics further fueled optimism about durable earnings growth.

Key takeaways

Adjusted EBITDA was $284 million, $29 million above the high end of prior guidance, with margins expanding 440 basis points year-over-year to 22.6%.
AA&S segment EBITDA margin improved markedly to approximately 22% from 14% a year ago, reflecting portfolio optimization, better pricing, and operational improvements.
Revenue grew 11% year-over-year to $1.3 billion, supported by a record backlog of $4.4 billion, up 18% annually and 7% sequentially, with more multiyear visibility.
Full-year adjusted EBITDA midpoint raised to $1.160 billion (35% growth), adjusted EPS midpoint to $5.04 (56% growth), and adjusted free cash flow midpoint to $575 million (51% growth).
Ongoing capacity expansions and operational improvements under the Elevation program contribute to sustainable productivity gains and support for long-term growth, despite some HPMC shipment timing delays.

View recap

Atmos Energy Corporation

ATO Q3 2026

Reported: 2026-08-08

Shares declined 1.2% following Atmos Energy’s earnings as investors digested margin pressures and a cautious operational outlook despite stable volume growth and reaffirmed EPS guidance.

Key takeaways

Fiscal year-to-date EPS of $7.33 reflects a 14.5% increase year-over-year, supported by customer growth and favorable rate increases.
Customer additions remain healthy with 51,000 new customers year-to-date, primarily in Texas, including industrial customers adding significant volume potential.
Margin compression is evident as spreads narrowed significantly starting in June due to new takeaway capacity coming online earlier than expected, impacting APT’s through-system business.
Operating and maintenance expenses are trending higher, with O&M guidance raised slightly to a range of $875 million to $885 million excluding net debt expense.
Capital expenditures remain elevated at approximately $4.2 billion for fiscal ’26, primarily focused on infrastructure for safety, reliability, and capacity expansion.

View recap

ATS Corporation

ATS.TO Q1 2027

Reported: 2026-08-08

ATS shares plunged 24.9% on disappointing top-line execution and margin pressure amid weaker-than-expected revenue and a cautious near-term outlook. The company’s 5% revenue decline, stemming from a lower order backlog and reduced large-scale automotive projects, and a 13% drop in adjusted operating earnings failed to reassure investors.

Key takeaways

Adjusted revenues declined 5% year-over-year due to lower opening backlog, timing of project execution, and intentional pullback in large automotive work.
Adjusted earnings from operations fell 13% to $68 million, reflecting the impact of a smaller revenue base on profitability.
Order backlog stands at approximately $1.9 billion, with strength in life sciences—particularly radiopharma—partially offset by softness elsewhere.
Fixed cost transformation program underway, aiming for $20 million in annualized savings from European operations as part of an 18-month efficiency drive.
Management emphasized long-term margin expansion and growth opportunities, but near-term execution challenges and ongoing restructuring tempered confidence.

View recap

Aura Minerals

AUGO Q2 2026

Reported: 2026-08-08

The stock surged 12.7% as investors responded positively to the company’s anticipated strong production ramp-up in the second half of the year and sustained EBITDA growth, despite weaker production and revenues in Q2.

Key takeaways

Q2 production was weaker than Q1, totaling 158,000 ounces in the first half of 2026, but management confirmed they remain on track to produce between 182,000 and 232,000 ounces in H2.
Revenues declined due to a lower gold price and reduced output, reaching $336 million for the quarter.
EBITDA approached $200 million, marking the 12th consecutive quarterly increase; trailing 12-month EBITDA was approximately $800 million.
All-in sustaining cash costs were elevated at around $2,000 per ounce, driven by a turnaround at MSG, but excluding this, costs were closer to $1,600 per ounce with expected improvement in H2.
The company generated $80 million in recurring cash flow (approximately $120 million before gold hedge losses), funding $54 million in expansion CapEx and returning $68 million to shareholders via dividends and buybacks; a new $60 million dividend and $200 million share buyback program were announced.

View recap

Axon Enterprise, Inc.

AXON Q2 2026

Reported: 2026-08-08

Axon's shares fell 14% as investors were disappointed by cautious outlook signals and indications of deceleration in key growth metrics despite management's emphasis on strategic long-term positioning.

Key takeaways

Market reaction suggests guidance or outlook raised concerns, although no explicit guidance cut was detailed in the transcript excerpt.
Management highlighted strong execution on large-scale deployments like the World Cup and ongoing growth in the Dedrone segment, but optimism did not translate to market confidence.
Emphasis on AI breakthroughs and integrated hardware-software ecosystems points to strategic vision rather than near-term financial upside.
No specific margin commentary was provided, but the significant share drop implies margin compression or slowing profitability metrics may have weighed on sentiment.
The narrative focused more on long-term structural positioning than immediate financial results, which likely failed to satisfy expectations.

View recap

Becton, Dickinson and Company

BDX Q3 2026

Reported: 2026-08-08

BD's shares rose 3.6% post-earnings, driven by revenue growth above expectations and an upward revision to adjusted EPS guidance, signaling market approval of the company’s focused portfolio and operational execution.

Key takeaways

Revenue reached $5 billion, up 4.4% year-over-year on an FX-neutral basis, with over 90% of the portfolio delivering high single-digit growth.
Adjusted operating margin expanded to 24.9%, reflecting improved mix and operational efficiency under the BD Excellence program.
Adjusted EPS came in at $3.23, prompting a raised midpoint for full-year EPS guidance and updated revenue growth target toward the high end of low single digits.
Broad-based growth was supported by double-digit expansion in biologic drug delivery, advanced patient monitoring, PureWick, and advanced tissue regeneration platforms.
Commercial investments in key segments like Advanced Patient Monitoring and PureWick contributed to accelerating growth and share gains, particularly in the U.S. market.

View recap

BlackSky Technology Inc.

BKSY Q2 2026

Reported: 2026-08-08

Shares of BlackSky Technology surged 15.8% following Q2 earnings as the company’s Gen-3 satellite platform and related AI-driven imagery subscription services materially outperformed expectations, driving substantial revenue growth and margin expansion.

Key takeaways

Total revenues grew 50% year-over-year, fueled by record space-based intelligence and AI services sales.
The company reached a $100 million annual run rate for high-margin imagery and AI subscription services, underpinning improved adjusted EBITDA.
Adjusted EBITDA margins expanded to 14%, reflecting operating leverage from the high-quality, capital-efficient Gen-3 satellite constellation.
YTD bookings hit up to $200 million, with increasing contract backlog enhancing revenue visibility.
International customer revenues grew 200%, marking diversification and broadening global footprint.

View recap

Bloomin' Brands, Inc.

BLMN Q2 2026

Reported: 2026-08-08

Bloomin’ Brands delivered a Q2 performance that significantly exceeded expectations, driving a 22.0% stock jump as comp sales growth across key restaurant brands and improving guest satisfaction metrics underscored progress in the Outback turnaround strategy.

Key takeaways

Total U.S. comparable restaurant sales increased 230 basis points year-over-year, despite a 190 basis point decline in traffic.
Outback Steakhouse comps rose 140 basis points with persistent traffic headwinds (-280 bps) attributed in part to deliberate shifts away from dilutive third-party delivery promotions.
Bonefish Grill showed the strongest traffic recovery, up 450 basis points, alongside comp sales growth of 810 basis points supported by promotional day-of-week offers.
Guest Metric Scores at Outback improved for the fourth consecutive quarter, including service (+7 points), atmosphere (+7 points), and food quality (+4 points), reflecting execution improvements such as a lower server-to-table ratio during peak hours.
The company remains committed to its four strategic pillars supporting the Outback turnaround, emphasizing guest experience, brand relevancy, culture, and investment, while balancing cost controls and capital allocation.

View recap

Blend Labs, Inc.

BLND Q2 2026

Reported: 2026-08-08

Shares of Blend fell 18.9% post-earnings, reflecting investor disappointment likely driven by cautious forward guidance and concerns about sustainability despite promising early Autopilot adoption metrics.

Key takeaways

Revenue landed near the high end of guidance, with non-GAAP operating income coming in above it, indicating controlled profitability in the quarter.
Autopilot became commercially available on July 1, with 65 lenders activating it in a four-month preview and early signs of 10-15% improvement in pull-through rates and 2-4 day cycle time reductions.
Autopilot currently automates about 4.5 hours of loan fulfillment tasks per loan, supporting increased operational efficiency claims.
Monetization strategy is evolving from flat-fee annual contracts to a success-based, per funded loan model, aligning revenue with customer outcomes.
Despite these innovations, management reiterated caution about the market environment and future quarters, which likely tempered enthusiasm and contributed to the steep stock decline.

View recap

Dutch Bros Inc.

BROS Q2 2026

Reported: 2026-08-08

Dutch Bros shares dropped 16.8% following the earnings release, reflecting investor disappointment likely driven by cautious management commentary and a lowered growth outlook despite reported transaction growth and revenue gains.

Key takeaways

Total revenues increased 32% year-over-year in Q2.
Adjusted EBITDA grew 28%, indicating solid profitability on reported numbers.
The company opened 48 new shops, reinforcing expansion momentum but raising questions about margin sustainability.
Despite transaction and comp sales growth, management’s tempered tone around future growth and acquisition impacts likely spurred investor concern.
Strong new market rollouts, including Chicago shops pacing at $7 million in volume, contrast with the cautious outlook that weighed on the stock.

View recap

Bentley Systems, Incorporated

BSY Q2 2026

Reported: 2026-08-08

Bentley Systems shares fell 2.3% following the Q2 2026 earnings release, reflecting investor caution despite management’s positive narrative on AI-driven long-term growth and infrastructure market positioning. The lack of stronger near-term financial guidance or clearly accelerated revenue growth likely tempered enthusiasm.

Key takeaways

Management highlighted ongoing double-digit growth consistency and expansion opportunities from AI integration across infrastructure engineering and asset management.
Bentley emphasized deep penetration within top global infrastructure owner-operator accounts outside China, with nearly 80% adoption and $330 million annual run rate spending.
AI-enabled digital twins and agentic API consumption models are positioned as future growth drivers but remain at an early stage of monetization.
The transcript did not provide updated guidance or specifics on margin trends, hinting at a cautious near-term outlook.
Market’s modest negative reaction suggests investors were not convinced that current results or outlook justify a premium re-rating.

View recap

Bioventus Inc.

BVS Q2 2026

Reported: 2026-08-08

Bioventus shares rose 4.2% post-earnings, driven by better-than-expected revenue growth and encouraging momentum across key growth segments, particularly Pain Treatments. The reaffirmation of full-year guidance and positive strategic developments underpinned investor optimism.

Key takeaways

Q2 revenue increased 4%, led by strong double-digit growth in the Pain Treatments segment, notably the HA franchise and DUROLANE product.
Year-to-date HA business outperformed expectations, enabling reinvestment into growth areas like PRP, PNS, Ultrasonics, and International markets.
Leading indicators such as accelerating PRP capital placements, increased surgeon adoption of PNS, and growing Ultrasonics disposable usage signal strengthening market traction.
International segment showing accelerating momentum due to targeted market focus and new talent additions, with expectations for strong double-digit growth in H2 and full year.
Company reiterated full-year guidance and disclosed a strategic review including potential sale options, reflecting management’s commitment to maximizing shareholder value.

View recap

Blackstone Secured Lending Fund

BXSL Q2 2026

Reported: 2026-08-08

Blackstone Secured Lending’s shares rose 5.1% post-earnings, reflecting investor approval of accelerating repayment activity and disciplined new deal funding, which together supported income and liquidity despite ongoing portfolio markdowns.

Key takeaways

Generated net investment income (NII) of $0.75 per share, representing an 11.4% annualized yield.
Portfolio NAV per share declined 2.8% quarter-over-quarter, with a total portfolio mark of 95.2%, driven by broader market spread widening and some underperforming assets.
Repayments accelerated sharply, reaching an annualized rate of 21% of portfolio fair value versus 13% last quarter and 5% year-over-year, enhancing liquidity and recycling capacity.
Continued focus on portfolio health with proactive management of bottom 10% marked at 70%, leveraging operational resources including a specialized value creation team.
Portfolio fundamentals showed steady EBITDA growth at 7% year-over-year and improved interest coverage of 2.1x; nonaccrual rates declined both at fair value (1.8%) and cost (3.6%).

View recap

Beyond Meat, Inc.

BYND Q2 2026

Reported: 2026-08-08

Beyond Meat’s shares plunged 16.8% after the company revealed continued revenue decline and persistent margin weakness weighed on investor sentiment, despite some sequential improvement and cost reductions.

Key takeaways

Net revenues declined 8.2% year-over-year to $68.8 million, though slightly above management’s guidance range.
Gross margin improved modestly to 8.5%, still low and burdened by accelerated depreciation from China operations, which suppressed margin by over two points.
Operating expenses fell 15% sequentially and 19% year-over-year, contributing to a modest EBITDA loss improvement to negative $27.7 million.
Cash usage (excluding financing) dropped 44% year-over-year to approximately $18 million.
Regional weakness persisted in U.S. retail and foodservice despite double-digit retail growth in Europe and Canada; ongoing misinformation campaigns continue to pressure U.S. sales.

View recap

CAI International, Inc.

CAI Q2 2026

Reported: 2026-08-08

Caris Life Sciences shares surged 24.2% following Q2 results as strong case volume growth and early enthusiasm for the Caris Detect multi-cancer early detection (MCED) test significantly exceeded investor expectations.

Key takeaways

Total cases reached a record 59,200 in Q2, representing an 18% year-over-year increase, driven by both tissue and blood testing volumes.
Over 345,000 clinical oncology tests were performed, including more than 114,000 Whole Exome and Whole Transcriptome tests.
The proprietary database grew to over 1.13 million profiled patients, supporting Caris' AI-driven comprehensive molecular oncology platform.
Caris Detect MCED test drew physician and patient interest surpassing management’s own forecasts, with near-term demand potentially outpacing rollout capacity.
Expansion of the Precision Oncology Alliance added key members, strengthening commercial reach and collaborative research.

View recap

Commerzbank AG

CBK.DE Q2 2026

Reported: 2026-08-08

The stock declined modestly by 0.9% following earnings despite a solid operational performance, likely reflecting investor caution about a mixed macroeconomic backdrop and the incremental nature of the outlook rather than outright disappointments.

Key takeaways

Revenues increased 7% year-on-year to EUR 6.5 billion, with operating profit up 14% to EUR 2.7 billion.
Net result reached a record EUR 1.8 billion, a 40% increase compared to the prior year.
Cost-income ratio improved to 53%, supporting operational leverage and cost discipline.
CET 1 ratio remains strong at 14.4%, supporting the planned capital return of EUR 3.2 billion with an 8% total yield targeted for 2026.
Management maintained a cautious yet optimistic outlook, slightly upgrading GDP growth expectations to 1% for 2026, but market reaction suggests some skepticism about sustained momentum amid macro and geopolitical uncertainties.

View recap

Cogent Communications Holdings, Inc.

CCOI Q2 2026

Reported: 2026-08-08

Shares plummeted 22.9% as investors reacted negatively to ongoing revenue declines and a cautious outlook, despite margin improvements and asset sales. The market clearly signaled disappointment with the lack of near-term revenue growth and uncertain trajectory on the Sprint customer base.

Key takeaways

Revenue declined year-over-year, driven by continued attrition in the acquired Sprint customer base, which management acknowledged is only now moderating.
Gross margin improved by 260 basis points year-over-year to 47%, supported by cost reductions and operational efficiencies, while adjusted EBITDA margin expanded to 30.2%.
The company monetized 10 former Sprint data center facilities, generating $225 million in cash proceeds and a GAAP gain of $130.7 million, using proceeds primarily to reduce leverage.
Net leverage decreased to 6.23x EBITDA from 6.79x last quarter, aided by debt repurchases and asset sales, but remains elevated overall.
Management reiterated multi-year revenue growth guidance of 6-8% but provided no near-term rebound, contributing to investor caution and the steep stock decline.

View recap

Century Aluminum Company

CENX Q2 2026

Reported: 2026-08-08

Shares jumped 9.2% following a solid quarter driven by the on-time completion and full ramp-up of key capacity expansions at Mount Holly and Grundartangi, which positioned the company to benefit from strong market conditions and favorable pricing.

Key takeaways

Mount Holly expansion completed on time and on budget, adding nearly 10% to U.S. aluminum production; full benefit to be seen starting Q3.
Grundartangi’s Line 2 restarted smoothly and ahead of schedule, running conservatively until replacement transformers arrive in Q4.
Jamalco brought a new power turbine online, enabling self-generated energy and reducing reliance on expensive grid purchases.
Market fundamentals remain robust with LME prices near preconflict levels and strong U.S. demand driven by infrastructure, aerospace, defense, and reshoring trends.
Some operational headwinds persist, including plant instability post-restart at Mount Holly and lower quality bauxite at Jamalco, but both are being actively managed.

View recap

IES Holdings, Inc.

CF Q2 2026

Reported: 2026-08-08

Shares declined 2% following CF Industries’ Q2 results, reflecting investor caution despite stable operational execution amid market uncertainty and only modest upward revisions to mid-cycle EBITDA guidance.

Key takeaways

Reported adjusted EBITDA of $2.2 billion for H1 2020, with Q2 adjusted EBITDA at $1.2 billion.
Operated ammonia capacity utilization near 98%, supporting strong asset efficiency.
Raised mid-cycle EBITDA and free cash flow expectations, but market reaction suggests limited upside beyond this.
Noted tight global nitrogen supply-demand balance sustained by geopolitical disruptions and elevated capital costs.
Customer purchasing slowed in June, impacting near-term volumes, though order books extended into November with expectations for a strong fall season.

View recap

Cognex Corporation

CGNX Q2 2026

Reported: 2026-08-08

Cognex shares dropped 5.4% following results that disappointed investors primarily due to cautious commentary around second-half growth moderation and margin pressure, despite solid near-term execution.

Key takeaways

Revenue reached a record level in Q2, driven by semiconductor, electronics, packaging, and logistics segments.
The company raised full-year logistics revenue guidance to high single-digit growth but flagged expected moderation in growth rates in H2.
Management emphasized progress in AI-enabled machine vision and new platform adoption but relied heavily on long-term diversification efforts that remain early in their contribution.
Adjusted EBITDA margin expanded in the quarter but investors appear concerned margins may face pressure given cautious outlook and ongoing investments in go-to-market and technology expansion.
Customer base expansion continues with over 4,500 new customers added year-to-date, supporting a “land and expand” growth strategy.

View recap

Chegg, Inc.

CHGG Q2 2026

Reported: 2026-08-08

Shares of Chegg declined 11.1% following the earnings release, reflecting investor disappointment likely driven by cautious outlook and signs of deceleration in key business segments amid the company’s transition to an AI-first model.

Key takeaways

Revenue and adjusted EBITDA reportedly outperformed internal expectations, though no specific figures were provided.
Management highlighted an ongoing strategic pivot to an AI-first approach aimed at building a scalable and sustainable cost structure.
The company is soft launching a new employability-focused platform in Q3, integrating academic, skilling, and job-matching services, with broader rollout expected in 2027.
Growth in the skilling segment remains a priority with six new partners signed this year, but no concrete near-term contribution details were shared.
Despite optimistic long-term vision, investors reacted negatively, suggesting concerns over near-term growth deceleration and margin pressure during the restructuring period.

View recap

Chime Financial, Inc. Class A Common Stock

CHYM Q2 2026

Reported: 2026-08-08

Chime’s Q2 earnings rallied the stock by 25.3% as revenue growth, margin expansion, and strong product adoption notably outperformed expectations, signaling robust momentum across both consumer and enterprise segments.

Key takeaways

Active members increased 20% year-over-year, while revenue grew 27%, driven by higher engagement and new product launches.
Adjusted EBITDA margin expanded 12 points to 15%, reflecting improved operating leverage alongside scaled growth.
The newly launched Chime Prime membership tier quickly gained traction, with prime members generating more than double ARPAM compared to the average customer.
Instant loan originations surged nearly 70% quarter-over-quarter to $300 million, with improving loss rates and an expected annualized revenue run rate exceeding $100 million by Q3.
Enterprise segment momentum accelerated with the signing of Allied Universal (320,000 employees) and a national retailer (35,000 employees), positioning this channel as a meaningful growth driver in 2027.

View recap

Clarus Corporation

CLAR Q2 2026

Reported: 2026-08-08

Shares jumped 10.4% as Clarus beat expectations driven by strong revenue growth and margin expansion in its Outdoor segment, supported by a sizable tariff refund and successful inventory management.

Key takeaways

Outdoor segment revenue grew 9.1% year-over-year, led by 7.4% growth in Mountain, 13.5% in Climb, and 7.4% in Apparel, with full-price Apparel sales up 22.9% and clearance down 61%.
Gross margin surged to 52.0% from 34.9% last year, boosted by a $6.1 million tariff refund; excluding the refund, margin still improved 160 basis points to 36.5%.
Adjusted EBITDA reached $9.0 million, though stripping out tariff and legal benefits, underlying EBITDA was $1.5 million, up from $0.3 million last year.
Adventure segment sales missed expectations despite a 420 basis point gross margin improvement, reflecting effective cost controls amid rescaling efforts.
Share repurchases continued under the $50 million program, with $0.4 million spent to buy back 153,331 shares, maintaining $42.4 million capacity.

View recap

Clean Energy Fuels Corp.

CLNE Q2 2026

Reported: 2026-08-08

Shares of Clean Energy Fuels plunged 16.2% following the quarter, reflecting investor disappointment with the cautious outlook amidst ongoing uncertainty over critical incentives and a lack of growth acceleration in key segments.

Key takeaways

Reported Q2 revenue of $106 million and adjusted EBITDA of $16 million, described by management as in line with expectations but failing to reassure the market.
RNG production improved modestly, aided by weather and project ramps, though ramp-up challenges remain and operational improvements are still needed.
Fuel volumes from heavy-duty trucking held steady, with no evident growth, hindered by fleets’ prebuying of legacy diesel trucks due to EPA uncertainty and delaying RNG adoption.
Delay in Treasury's finalization of the Section 45Z clean fuel production credit rules, critical for RNG economics, adds to near-term regulatory risk with final guidance now expected in Q4.
Incremental progress in hydrogen fueling infrastructure and alternative power solutions showcased but appears insufficient to offset investor concerns on near-term growth and margin pressures.

View recap

Compass Minerals International, Inc.

CMP Q3 2026

Reported: 2026-08-08

Shares dropped 8.9% as investors reacted negatively to signs of margin pressure and operational cost challenges in the salt business, despite solid pricing in key segments and raised guidance in plant nutrition.

Key takeaways

Plant Nutrition segment delivered $15 million in adjusted EBITDA with improved pricing and lower per-unit costs; full-year guidance for this business was raised.
Salt business saw meaningful price gains in highway de-icing and early signs of better pricing in the commercial & industrial segment.
Production costs at salt mines remained higher than expected due to lower-than-planned output at Goderich, increased maintenance spending, and higher headcount.
Operational improvements are underway but have not yet translated into the anticipated cost efficiencies, pressuring margins.
Management changed operational leadership, signaling a focus on resolving ongoing execution issues and stabilizing mine production.

View recap

ConocoPhillips

COP Q2 2026

Reported: 2026-08-08

Shares rose modestly by 2.2% following ConocoPhillips' Q2 report as production and free cash flow met high expectations, but the market remained cautious on forward growth drivers and overall outlook.

Key takeaways

Q2 production reached 2.248 million barrels of oil equivalent per day, exceeding the high end of guidance, with the Permian achieving a record >900,000 boe/d.
Free cash flow totaled $4.2 billion after $3 billion in CapEx, underpinning a $3 billion shareholder distribution, including a doubling of share repurchases to $2 billion.
The company completed its $5 billion noncore asset disposition target ahead of schedule, capturing strong value from recent sales.
Full-year guidance remains unchanged, with expected production growth in Q3 driven by Qatar ramp-up and Lower 48 expansion offsetting divestitures.
Management reiterated the 2029 target of $7 billion free cash flow but provided limited incremental detail on near-term growth or margin expansion catalysts.

View recap

Copa Holdings, S.A.

CPA Q2 2026

Reported: 2026-08-08

Shares fell 5.7% as investors reacted negatively to margin pressure driven by a sharp 85% increase in fuel costs and only modest load factor improvement despite capacity growth. The cautious outlook amid rising operational expenses overshadowed steady revenue growth and operational reliability.

Key takeaways

Operating profit came in at $91.7 million with an operating margin of 8.7%, compressed by an 85% rise in all-in fuel costs versus Q2 2025.
Capacity expanded 16.5% (ASMs), but load factor slightly declined to 86.7% from 87.3% year over year, partly due to the World Cup impact lowering June load factors by 2.3 points.
Passenger yield increased 8.7%, and unit revenue (RASM) rose 7.9% to 11.6 cents, though these were not enough to fully offset the fuel cost surge.
Operational metrics remain a highlight with 90.6% on-time performance and 99.8% flight completion factor, sustaining Copa’s reputation for reliability.
Network expansion continues with the addition of a new leisure destination in Venezuela and completion of Starlink onboard internet rollout expected by mid-2027, but fleet growth is cautiously managed with only one more Boeing 737 MAX 8 delivery anticipated for the year.

View recap

CVS Health Corporation

CVS Q2 2026

Reported: 2026-08-08

CVS Health's stock fell 7.9% following the earnings release as investors were disappointed by signs of deceleration in key segments and cautious outlook indicators, despite management’s emphasis on growth initiatives and raised full-year guidance.

Key takeaways

Adjusted operating income was $5.2 billion and adjusted EPS of $2.58 for the quarter.
Management raised full year adjusted EPS guidance to a range of $7.90 to $8.10 and increased expected cash flow from operations by $2 billion to at least $11.5 billion.
GLP-1 therapies continue to drive business focus, with pricing initiatives and direct-to-consumer channels aiming to address affordability and access challenges.
Continued investment in digital platforms like the Health100 and AI assistant Haio targets improved consumer engagement but early impact remains uncertain.
Operational improvements include AI-enabled claims processing and expanded clinical collaboration, but incremental near-term benefits may be limited amid slower growth dynamics.

View recap

Curtiss-Wright Corporation

CW Q2 2026

Reported: 2026-08-08

Shares dropped 7.6% as investors reacted negatively to softer Defense Electronics sales and cautious demand, particularly due to order timing headwinds in naval programs and a 3% decline in defense segment revenues that contrasted a stronger overall sales growth.

Key takeaways

Consolidated revenue rose 5% year-over-year to $924 million, driven by solid Aerospace & Industrial (A&I) segment growth; Defense Electronics sales fell 3%.
Operating income increased 12%, with 110 basis points of margin expansion, aided by favorable mix and restructuring savings offsetting higher development investments.
Defense Electronics orders grew nearly 50% year-over-year but operating segment sales were pressured by timing issues, especially lower tactical communications sales and second quarter naval order weakness.
Full-year sales guidance raised to 8-9% growth and operating margin expansion of 50-70 basis points, supported by improved defense and industrial markets projections.
Free cash flow generation improved 37% to $160 million with a conversion rate of 115%, underpinning continued investment in growth initiatives despite segment headwinds.

View recap

Dana Incorporated

DAN Q2 2026

Reported: 2026-08-08

Dana’s shares edged up 1.5% post-earnings, reflecting a steady quarter that delivered on cost savings and strategic initiatives but showed no clear upside catalyst to drive a stronger market response.

Key takeaways

Sales reached $2 billion with adjusted EBITDA of $207 million; margins improved 270 basis points year-over-year to 10.3%.
Achieved $19 million in quarterly cost savings, bringing the year-to-date total to $54 million toward the $65 million 2026 target.
Restarted share repurchase program, repurchasing 1.2 million shares for $44 million in Q2 and planning $200 million more for the rest of the year.
Dana 2030 growth strategy progressing with notable aftermarket sales gains (+$40 million from national retail chains) and new defense-related sales estimated at $30 million.
Eaton Mobility transaction structure updated to a split-off, maintaining tax-free status and allowing ongoing share repurchases through deal closing.

View recap

Datadog, Inc.

DDOG Q2 2026

Reported: 2026-08-08

Datadog shares fell 17.4% after earnings as investors reacted negatively to cautious guidance and signs of margin pressure despite solid top-line growth and product adoption. The pronounced stock drop signals that the outlook and margin trends disappointed relative to expectations.

Key takeaways

Q2 revenue grew 36% year-over-year to $1.12 billion, exceeding the high end of the company’s guidance range.
Customer count rose to approximately 33,400, with 4,720 customers generating $100,000 ARR or more, accounting for 91% of ARR.
Product adoption expanded, with 58% of customers using 4+ products and real user monitoring (RUM) ARR surpassing $200 million at over 50% growth.
Free cash flow was $279 million, yielding a healthy 25% margin, but investors appeared concerned about margin compression going forward.
Management framed revenue acceleration and innovation across AI and observability products, but cautious forward-looking statements and implied challenges in margin expansion weighed on sentiment.

View recap

Dragonfly Energy Holdings Corp. Common Stock (NV)

DFLI Q2 2026

Reported: 2026-08-08

Shares rallied 13.8% as Dragonfly delivered better-than-expected adjusted EBITDA and showcased initial revenue momentum in heavy-duty trucking, marking a key commercial inflection after years of pilot programs.

Key takeaways

Adjusted EBITDA improved by $3 million sequentially, driven by cost actions implemented earlier in the year.
Heavy-duty trucking segment contributed approximately $0.5 million in Q2 revenue, with expectations to more than double in Q3 to $1.3 million.
Acquisition of Dakota Lithium’s assets expands product portfolio and market reach, with $12 million in 2025 net revenue and anticipated accretive impact to EBITDA by Q4.
Amendments to term loan agreement provide enhanced liquidity and financial flexibility through mid-2027.
Company continues to strengthen IP position with new patent allowances in Japan supporting solid-state battery technology.

View recap

Deutsche Post AG

DHL.DE Q2 2026

Reported: 2026-08-08

Shares declined 4.2% following results as investors reacted to cautious free cash flow dynamics and ongoing volatility despite revenue acceleration and EBIT growth.

Key takeaways

Group revenue accelerated 13% year-over-year, while EBIT increased by 30%, driven by successful execution of the Fit for Growth program and effective yield and capacity management.
Free cash flow was impacted by growth-related working capital buildup and a temporary, one-off tariff refund payment that requires repayment to customers, limiting near-term cash conversion.
Volume growth in the Express segment improved steadily, maintaining momentum particularly in targeted industrial verticals such as semiconductors, automotive, and new energy sectors.
Currency headwinds present in prior quarters abated, stabilizing organic growth trends for Q2.
Despite management’s confidence and raised guidance, the cautious tone on cash flow and ongoing market uncertainties likely weighed on investor sentiment.

View recap

The Walt Disney Company

DIS Q3 2026

Reported: 2026-08-08

Disney’s stock rose 6.6% following fiscal Q3 results, driven by stronger-than-expected operating income growth and robust performance in Disney Experiences and Disney+. The market rewarded the diversified entertainment model and solid execution across multiple franchises and consumer touchpoints.

Key takeaways

Total segment operating income increased 21% year-over-year, exceeding prior guidance.
Company-wide revenue grew 7%, with Disney Experiences hitting record fiscal Q3 revenue and operating income.
Core platforms—Disney Experiences, Disney+, and ESPN—all showed growth in guests, users, and audiences versus the prior year.
Disney+ achieved a 13% SVOD operating margin in the quarter, on track for double-digit margins by fiscal 2026 (excluding the 53rd week).
Strong IP franchises, exemplified by Toy Story 5 surpassing $1 billion global box office and record NBA/NHL viewership on ESPN, underpinned performance despite mixed box office outcomes in other studio releases.

View recap

Derwent London Plc

DLN.L Q2 2026

Reported: 2026-08-08

Shares declined 0.6% as investors digested modest outward yield shifts and a significant provision at Old Street Quarter, which weighed on net asset value despite steady underlying operational performance.

Key takeaways

EPRA earnings for H1 slightly exceeded guidance, prompting a 2026 earnings upgrade.
Property portfolio saw a 6 basis point outward yield shift, impacting valuations; adjusted for transactions, yield movement was closer to 15 basis points.
EPRA net tangible assets declined 2.1%, driven by valuation deficits and a GBP 45.8 million provision related to the Old Street Quarter acquisition.
Rental income was marginally down year-over-year due to vacancies linked to ongoing projects and sales marketing, partially offset by new lettings including the fully pre-let Network development.
Disposals of GBP 280 million reduced leverage and enabled a GBP 50 million share buyback program, supporting balance sheet strength amidst cautious market conditions.

View recap

Amdocs Limited

DOX Q3 2026

Reported: 2026-08-08

Amdocs shares gained 4.2% following the quarter as Managed Services delivered a record revenue contribution and the company secured a significant multiyear partnership, driving investor optimism about its strategic shift toward the Agentic era.

Key takeaways

Q3 revenue was $1.175 billion, and non-GAAP diluted EPS came in at $1.84, both aligning with guidance midpoints.
Non-GAAP operating margin improved by 20 basis points year-over-year, balancing growth investments with cost efficiencies.
Managed Services accounted for 67% of total revenue, marking a record contribution to the quarter.
The company’s 12-month backlog reached $4.26 billion, up 2.7% from a year ago, indicating steady demand visibility.
Closed a landmark 10-year partnership with Liberty Latin America to manage and transform its end-to-end IT ecosystem using the new Agentic Telco Operating System (aOS), underscoring progress in its strategic transformation.

View recap

Medical Facilities Corporation

DR.TO Q2 2026

Reported: 2026-08-08

Medical Facilities' stock dropped 12.2% following the release, reflecting investor disappointment with volume declines in key inpatient and pain management segments despite revenue growth and margin stability.

Key takeaways

Facility service revenue rose 7.8% year-over-year, driven mainly by a favorable case mix weighted towards higher-value orthopedic and spine procedures.
Surgical case volume declined 2.3%, with inpatient cases down 12.5% and pain management volumes dropping nearly 20%, signaling weaknesses in key service lines.
Operating expenses increased 7.6%, driven by a 12.5% rise in drugs and supplies costs and a 6.4% increase in salaries and benefits, limiting margin expansion despite higher revenue.
Income from operations grew 9.4% to $9.6 million and EBITDA increased 7.1% to $12.5 million, but gains were insufficient to offset concerns about segment deceleration.
The company remains debt-free at the corporate level with a strong liquidity position of $64.1 million in cash, supporting ongoing capital returns and operational flexibility.

View recap

eBay Inc.

EBAY Q2 2026

Reported: 2026-08-08

eBay's shares inched up just 0.5% following Q2 results that generally met expectations but showed no clear catalysts to drive a more decisive market reaction.

Key takeaways

Gross merchandise volume (GMV) grew 14% year-over-year to over $22 billion, supported by broad-based marketplace momentum.
Revenue increased 14% to more than $3 billion, in line with guidance and consensus expectations.
Non-GAAP operating income and earnings per share rose 16% and 17%, respectively, reflecting controlled margin trends.
Focused categories, including collectibles, motors, fashion, and recommerce, each grew over 20%, accounting for more than 70% of total GMV.
Initiatives like AI-powered tools, expanded authenticity guarantees, and faster vehicle transaction processes continue to support user experience but have yet to accelerate growth beyond current trends.

View recap

Okeanis Eco Tankers Corp.

ECO Q2 2026

Reported: 2026-08-08

The 7.7% stock jump reflects clear investor approval of Okeanis Eco Tankers' record earnings driven by exceptionally strong freight rates and substantial dividend payouts, signaling superior operational performance and value returned to shareholders.

Key takeaways

Adjusted EPS reached a record $5.91 in Q2 and $8.28 for the first half of 2026, supported by fleet-wide TCE averaging around $181,000 per vessel per day.
Spot VLCC and Suezmax rates soared to $214,000 and $175,000 per day respectively, underpinning the top-line strength.
The company declared its 17th consecutive quarterly dividend of $5.25 per share, the highest quarterly payout since inception, distributing nearly 90% of net income.
Fleet expanded to 18 modern, eco scrubber-fitted vessels, fully delivered as planned, driving enhanced operational capacity with utilization at 99%.
Financial position remains solid with $248 million in cash, manageable leverage at 35% book basis and below 25% on market-adjusted LTV, alongside reduced average borrowing costs by over 200 basis points.

View recap

Element Fleet Management Corp.

EFN.TO Q2 2026

Reported: 2026-08-08

Element’s shares dropped 5.9% after the quarter, reflecting investor disappointment likely driven by cautious outlook signals and margin pressure despite top-line growth.

Key takeaways

Adjusted net revenue rose 10% year-over-year to $318 million, supported by solid contributions across business segments.
Vehicles under management grew 3% to 1.56 million, within targeted growth range of 2–4%.
Service revenue increased 8%, reflecting reacceleration, while net financing revenue grew 7% despite elevated credit loss provisions fully accounted for.
Core net financing revenue yield improved by 35 basis points to 5.12%, but credit loss provision linked to a client-specific matter weighed on margin expansion.
Ongoing investments in digital transformation and organizational restructuring expected to yield $20 million in annualized savings starting 2027, signalling near-term cost pressure.

View recap

Entegris, Inc.

ENTG Q2 2026

Reported: 2026-08-08

Shares rose 4.5% following Entegris’s earnings report, driven by better-than-expected revenue growth, margin expansion, and an upgraded industry outlook that reflects accelerating AI-related semiconductor demand and strong capital spending momentum.

Key takeaways

Revenue grew 11% year-over-year, surpassing guidance on both unit-driven (+10%) and CapEx-related (+15%) businesses.
Adjusted gross margin improved sequentially to the highest level since early 2022, reflecting operational efficiency gains and portfolio optimization efforts.
Free cash flow reached $120 million (14% of sales), enabling a $200 million debt repayment and reducing net leverage to 3.4x, with expectations to reach high 2x by year-end.
Management highlighted increasing semiconductor capital investments, tracking over 20 major leading-edge fab expansions globally, signaling durable industry growth.
Continued focus on core semiconductor markets included exiting non-core Life Sciences Fluid Management and closing a dilutive facility to streamline operations.

View recap

Energy Recovery, Inc.

ERII Q2 2026

Reported: 2026-08-08

Shares dropped 4.3% following the quarter as investors reacted negatively to ongoing delays and uncertainty in project execution, particularly in the Middle East, which undermined visibility and growth timing despite a strong underlying pipeline.

Key takeaways

The company highlighted a strong and long-term sales pipeline extending up to five years, but acknowledged formalized delays driven by geopolitical risk, financing issues, and logistical challenges.
The timing of project starts and executions remains uncertain, creating cautious near-term visibility.
Manufacturing transformation efforts, including a new facility in Saudi Arabia, are expected to improve margins gradually over the next several years, but no immediate uplift is anticipated.
Wastewater market opportunities are expanding, with ongoing investment in product diversification and go-to-market realignment, targeting growth particularly in Asia.
Management reiterates disciplined cost control and capital efficiency amid macro uncertainties but offers limited clarity on a near-term rebound.

View recap

Etsy, Inc.

ETSY Q2 2026

Reported: 2026-08-08

Etsy's shares dipped modestly by 0.4% following Q2 results that showed sequential acceleration in marketplace growth but a cautiously measured recovery in buyer engagement and purchase frequency, leaving some investor concerns about the pace of sustained improvement.

Key takeaways

Marketplace Gross Merchandise Sales (GMS) increased 7.5% year-over-year to $2.6 billion, marking the third consecutive quarter of YoY growth.
Revenue rose to $668 million with a stable take rate of 25.9%; adjusted EBITDA was $195 million, representing a 29.2% margin.
Active buyers grew sequentially by 350,000 to approximately 87 million but remained roughly flat year-over-year.
Purchase frequency, while still below prior year levels, showed a moderated decline compared to Q1, signaling initial progress on customer engagement.
Investments in younger demographics and personalization continue, supported by notable app growth (12.5% YoY) and increased traffic via social media platforms.

View recap

Expensify Inc. Class A Common Stock

EXFY Q2 2026

Reported: 2026-08-08

Expensify's shares surged 33.2% following better-than-expected profitability improvements and a significant share repurchase program, signaling investor approval despite ongoing revenue decline and paid member softness.

Key takeaways

Q2 revenue declined year-over-year to $33.9 million, reflecting ongoing top-line pressure.
Average paid members decreased slightly to 640,000 in Q2 and 634,000 in July, consistent with typical seasonality but showing limited growth momentum.
Operating cash flow was $8.4 million, with free cash flow rising 2% year-over-year to $6.4 million and up 162% sequentially.
GAAP net loss narrowed substantially to $3.9 million from $8.8 million a year ago; non-GAAP net income turned positive at $3.4 million.
Management increased full-year free cash flow guidance from $6–$9 million to $12–$14 million, reflecting strong cash generation.

View recap

EZCORP, Inc.

EZPW Q3 2026

Reported: 2026-08-08

EZCORP’s shares fell 6.3% as investors digested margin compression in the scrap segment and a cautious sequential outlook despite underlying growth in core pawn metrics and expansion in Latin America.

Key takeaways

Adjusted EBITDA rose 48% to $65.6 million and adjusted EPS increased 47% to $0.47, driven largely by merchandise margin expansion and operating leverage.
Core pawn revenues grew 24% and same-store core pawn gross profit increased 13%, reflecting solid demand and disciplined lending across markets.
Scrap sales declined sequentially due to gold price stabilization, with scrap gross margin dropping to 26% from 38% in the prior quarter, pressuring overall margins.
Latin America stood out with 33% constant currency growth in PLO and 40% segment EBITDA growth, aided by store acquisitions and new openings.
U.S. Pawn segment saw 14% revenue growth and 23% EBITDA growth, supported by higher average loan sizes and improved merchandise margin, though inventory levels rose significantly.

View recap

Fiserv, Inc.

FISV Q2 2026

Reported: 2026-08-08

Fiserv shares fell 3.1% after the company lowered its full-year organic revenue and margin guidance, driven by weaker macro conditions, slower growth execution, and increased investments weighing on profitability.

Key takeaways

Full-year organic revenue guidance cut to a range of -1% to flat, reflecting deceleration amid challenging conditions.
Adjusted operating margins lowered to 31%–31.5%, pressured by incremental technology, infrastructure, and cybersecurity investments.
Macro weakness in Argentina and delayed client implementation timelines cited as external headwinds.
Growth initiatives progressing slower than expected, prompting management to refocus efforts and improve operational execution.
CEO emphasized a strategic shift to streamline the product portfolio, prioritize capital allocation, and drive operational discipline.

View recap

JFrog Ltd.

FROG Q2 2026

Reported: 2026-08-08

JFrog’s Q2 revenue and cloud growth beat expectations, driving a 5.9% stock increase as the market rewarded robust demand for its cloud platform amid rising AI-driven software supply chain activity.

Key takeaways

Total revenue reached $163.8 million, growing 29% year-over-year.
Cloud revenue surged 53% YoY, supported by increased consumption of secure binaries.
Enterprise customers with annual spend over $1 million grew 59% to 97, highlighting strong upsell motion.
Customers spending more than $100,000 annually rose 20% to 1,291, reinforcing broad-based enterprise traction.
Management emphasized the strategic positioning of JFrog as the control plane for AI-accelerated software supply chains, fueling cloud demand despite ongoing customer forecasting challenges.

View recap

Formula One Group

FWONA Q2 2026

Reported: 2026-08-08

Liberty Media's shares gained 6.4% as Formula One's digital viewership growth and new sponsorship deals demonstrated resilience despite a significant race count-related revenue decline; MotoGP's strengthened agreements and fan engagement initiatives also contributed to investor optimism.

Key takeaways

Formula One's year-to-date revenue declined 15% and adjusted OIBDA fell 30%, driven primarily by a 27% reduction in race count impacting season-based revenue recognition.
Underlying contractual fee increases and new sponsorships partially offset softer media rights revenue, which was also affected by last year's one-time F1 movie revenue.
F1 viewership on Apple TV rose 13% year-over-year, attracting a younger and more female audience, supporting momentum in digital distribution and sponsorship assets.
MotoGP secured manufacturer and team agreements through 2031, positioned for long-term commercial growth alongside new media deals in Europe and successful fan activations.
Calendar adjustments include rescheduling the Bahrain GP to October (in Malaysia) and an expectation of a return to a full 24-race schedule next season.

View recap

Assicurazioni Generali S.p.A.

G.MI Q2 2026

Reported: 2026-08-08

Generali’s H1 2026 results showed moderate gains in premiums, operating results, and net income, with a modest market reaction of +0.4%, reflecting investor neutrality amid offsetting factors including natural catastrophe claims pressure.

Key takeaways

Gross written premium increased 5.8% to EUR 53.4 billion, led by Life and Property & Casualty segments.
Operating result grew 11.2% to EUR 4.5 billion, with Life up 8.8% to EUR 2.2 billion and Property & Casualty rising 4.7% to over EUR 2.1 billion despite EUR 425 million additional natural catastrophe and man-made loss claims.
New business value in Life jumped 21.1% to EUR 1.9 billion, and the new business margin expanded to 5.86% on improved product mix and features.
Asset & Wealth Management operating result increased 31.3%, contributing about 16% of the group’s total operating income.
The combined ratio in Property & Casualty worsened slightly to 91.5% from 91%, impacted by a 3.6 percentage point hit from natural catastrophes and ongoing inflationary pressures expected to influence pricing going forward.

View recap

GoodRx Holdings, Inc.

GDRX Q2 2026

Reported: 2026-08-08

Shares rallied 12.5% following GoodRx’s Q2 report, driven by better-than-expected revenue growth—most notably a 76% year-over-year surge in Pharma Direct revenue—and an upgraded full-year outlook reflecting increased confidence in returning to year-over-year growth sooner than anticipated.

Key takeaways

Pharma Direct revenue accelerated 76% year-over-year and 18% quarter-over-quarter, led by expanded consumer direct pricing programs including major brands like Jardiance and Otezla.
GLP-1 medication demand remains robust, with GoodRx supporting several new launches, solidifying its role as a key consumer access channel in this high-growth segment.
Subscription initiatives, including the recent launch of GoodRx Companion, are becoming increasingly central to customer retention and engagement strategies.
Management raised full-year revenue and adjusted EBITDA guidance based on strong Q2 trends, signaling confidence in sustaining growth momentum.
Leadership change: previously Chief Strategy and Operations Officer Justin Fengler appointed CFO, ensuring continuity in financial leadership amid the company’s strategic evolution.

View recap

Gen Digital Inc. Common Stock

GEN Q1 2027

Reported: 2026-08-08

The stock reacted positively, rising 4.4%, driven by better-than-expected revenue growth and a strong margin profile, supported by accelerating demand across both Cyber Safety and Trust-Based Solutions segments.

Key takeaways

Bookings and revenue grew 11% year-over-year, surpassing previous guidance.
Non-GAAP EPS increased 19%, reflecting operational leverage and disciplined cost management.
Paid customers exceeded 80 million, marking the 11th consecutive quarter of sequential growth.
Cyber Safety segment sustained mid-single-digit growth with margins above 50%, boosted by deployment of AI-driven products like Norton’s Financial Scan.
Trust-Based Solutions bookings expanded 25%, driven by higher-tier plan adoption and strong retention (90% retention, NPS above 70).

View recap

The GEO Group, Inc.

GEO Q2 2026

Reported: 2026-08-08

Shares declined 2.3% following a solid quarter that nevertheless fell short of fully alleviating investor concerns around cautious near-term outlook and ongoing operational challenges in scaling certain services.

Key takeaways

Revenue rose 15% year-over-year, driven primarily by new and expanded ICE contracts secured in 2025, adding approximately $520 million in potential annual revenue.
Net income increased 63% compared to the prior year, reflecting improved profitability on contract ramps.
ICE bed census grew by 20% in recent weeks to about 24,000 active beds, supported by significant federal appropriations under the Secure America Act.
Two new 5-year contracts for reactivating facilities in Colorado and North Carolina are expected to add ~$165 million in annual revenues by early 2027 but remain non-contributory this year.
Despite these positives, roughly flat market reaction implies skepticism about sustainability and margin pressure risks amid ongoing reactivation costs and uncertainties in contract ramp timing.

View recap

Glencore plc

GLEN.L Q2 2026

Reported: 2026-08-08

Glencore’s shares rose modestly by 2.8% following first half 2026 results that broadly met expectations. The company delivered stable operational performance and maintained its guidance, supported by solid industrial EBITDA and a near-record marketing EBIT, though the market response reflects a measured view on growth prospects and input cost pressures.

Key takeaways

Adjusted industrial EBITDA reached $6.5 billion, driven by stronger Metals and Minerals prices, alongside resilient energy and steelmaking coal contributions despite higher input costs, particularly diesel.
Adjusted marketing EBIT was $3.3 billion, approaching record levels, benefiting from disrupted energy and freight markets creating lucrative trading opportunities.
Funds from operations more than doubled to $8.1 billion (+158%), enabling a $1.5 billion shareholder return package split between $1 billion in cash and $0.5 billion buybacks.
Operational guidance was maintained with production on track within the established ranges for the second consecutive year.
Key copper growth projects progressed with Alumbrera restart ahead of schedule (production now expected late 2027), land secured at KCC extending mine life, and ongoing permitting with no indications of delays.

View recap

Genmab A/S

GMAB.CO Q2 2026

Reported: 2026-08-08

Genmab’s shares rose 5.7% post-earnings, reflecting investor approval of strong revenue growth and robust commercial execution, particularly driven by the significant sales acceleration of EPKINLY and expanding late-stage pipeline momentum.

Key takeaways

Total revenue increased 25% year-over-year, underpinned by broad portfolio growth.
EPKINLY sales rose 48% year-over-year to $312 million in H1, with new patient starts and site activations driving growth, especially in the US.
Proprietary product portfolio sales grew 37% to $396 million, reflecting solid commercial traction.
Pipeline progress includes positive Phase III results for EPCORE DLBCL-4 and European approval of TEPKINLY, signaling clinical and regulatory advances.
Genmab confirmed ongoing late-stage development progress with multiple upcoming Phase III readouts in late 2026 and early 2027 across key indications.

View recap

Global Net Lease, Inc.

GNL Q2 2026

Reported: 2026-08-08

Shares gained 7.1% as investors welcomed the accretive Modiv acquisition and continued capital recycling efforts that enhance portfolio quality and cash flow durability.

Key takeaways

Proposed acquisition of Modiv expected to close mid-August 2026, extending portfolio lease term to 6.6 years and increasing industrial exposure to ~50% of straight-line rent.
Modiv deal projected to be ~4% accretive to AFFO per share while remaining leverage-neutral.
Disposition pipeline of $263 million through July 31, 2026, with 78% office assets, reducing office exposure to an anticipated 21% of total rent.
Sold office properties at ~7.2% cash cap rate; continuing to monetize non-core office assets on lease expirations to avoid re-leasing risk.
Acquired a $14 million FedEx-leased industrial property at an 8.2% cap rate, illustrating value creation through capital recycling.

View recap

Gladstone Commercial Corporation

GOOD Q2 2026

Reported: 2026-08-08

Gladstone Commercial’s stock gained 5.8% post-earnings, reflecting investor approval of significant industrial acquisitions and sustained high portfolio occupancy despite modest office segment challenges and capital expenditures.

Key takeaways

Acquired a 153,890 sq ft industrial property in Newport News, VA for $22.75 million, nearly doubling cash and rent contributions compared to the recently sold North Carolina industrial asset.
Sold a 161,458 sq ft industrial building in Monroe, NC, fully occupied during ownership, generating a gain and reallocating capital into higher-yielding industrial assets.
Maintained a high portfolio occupancy rate of 98.7% with a weighted average lease term (WALT) exceeding 7.1 years.
Industrial assets now represent 69% of annualized straight-line rent, moving toward the target of 70% concentration.
Continued selective office leasing with a focus on manageable CapEx and attractive returns, while prioritizing industrial growth and portfolio quality.

View recap

Global Payments Inc.

GPN Q2 2026

Reported: 2026-08-08

Shares dipped 0.6% following Global Payments’ Q2 results as investors weighed moderate revenue growth against cautious commentary on external headwinds and ongoing integration risks, resulting in a broadly neutral market response.

Key takeaways

Adjusted net revenue grew 4% on a normalized basis, factoring in a ~100 basis point headwind from the Middle East conflict impacting the travel portfolio.
Adjusted operating margins expanded by 70 basis points, showing modest margin improvement despite integration costs.
Adjusted EPS rose 12%, reflecting operational discipline and share repurchases.
Integration of Worldpay is progressing, including leadership alignment and technology consolidation aiming for long-term value, but no near-term synergy quantification provided.
SMB segment showed encouraging trends with a 30% increase in new merchant locations per sales rep and over 25% sequential increase in Genius bookings, though Genius revenue remains modest today.

View recap

Green Plains Inc.

GPRE Q2 2026

Reported: 2026-08-08

Shares fell 11.2% as investors reacted negatively to a cautious outlook and limited upside in core ethanol operations despite solid carbon platform results, signaling concerns about growth sustainability and margin pressure.

Key takeaways

Adjusted EBITDA rose to $93.3 million in Q2, up from $71.5 million in Q1, largely driven by the carbon platform’s $59 million contribution.
Ethanol production was steady at nearly 161 million gallons with capacity utilization at 90%, reflecting planned maintenance downtime.
Carbon credits continue to add value, with no monetization of 2026 credits yet and management maintaining a cautious, patient approach to maximize returns.
Operating cash flow was solid at nearly $87 million; liquidity remains healthy with $243 million in cash against $484 million in total debt.
Despite near-term operational stability, the company did not incorporate positive potential demand catalysts in guidance, suggesting a conservative outlook that failed to reassure the market.

View recap

The Goodyear Tire & Rubber Company

GT Q2 2026

Reported: 2026-08-08

Goodyear shares dropped 7.2% after the quarter as the market reacted negatively to ongoing margin pressure in the Americas and a cautious outlook driven by competitive headwinds, despite some regional improvements.

Key takeaways

Americas region continued to face challenges with a soft consumer backdrop and competitive pressure impacting margins.
Asia Pacific was a rare bright spot, delivering volume growth, revenue expansion, and improved margins across both consumer and commercial segments.
Global tire volumes increased sequentially, helped by moderated channel destocking and stable market conditions.
The portfolio shift toward larger rim sizes (18-inch and up) continued, with a 4-point year-over-year increase in consumer mix.
Manufacturing footprint adjustments, including the planned closure of the Fayetteville facility by end-2027, aim to reduce costs by $90 million in 2027 and $270 million thereafter, but benefits are still a few years away.

View recap

Gran Tierra Energy Inc.

GTE Q2 2026

Reported: 2026-08-08

Gran Tierra's shares surged 38.7% post-earnings, driven by stronger commodity prices, improved margins, and notable free cash flow generation, which collectively outpaced investor expectations.

Key takeaways

Net income was $25 million, a turnaround from prior losses of $119 million last quarter and $13 million year-over-year.
Adjusted EBITDA rose to $85 million from $74 million in the prior quarter and $77 million a year ago.
Funds from operations improved 41% sequentially to $60 million ($1.70/share) and rose 12% year-over-year.
Free cash flow reached approximately $6 million, more than doubling the $2.7 million generated in Q2 2025.
Operationally, the company completed its $123 million Suroriente capital carry commitment and advanced its Tisquirama working interest agreement, enhancing future cash generation prospects.

View recap

ZoomInfo Technologies Inc.

GTM Q2 2026

Reported: 2026-08-08

Shares jumped 14.4% as ZoomInfo delivered modest revenue growth combined with margin expansion and solid free cash flow, bolstered by strong upmarket customer traction and strategic product initiatives that resonated with investors.

Key takeaways

GAAP revenue rose 1.2% year-over-year to $310 million, reflecting ongoing top-line moderation.
Adjusted operating income increased 5% year-over-year, with margins expanding 130 basis points to 35%.
Unlevered free cash flow grew 7% to $107 million, underpinning a disciplined focus on profitability and cash generation.
Upmarket ACV now constitutes 76% of total ACV, with upmarket growth at 3% year-over-year and key expansions with large enterprise customers.
The company launched GTM.AI and began testing a consumption-based pricing model, signaling a shift toward flexible packaging aimed at long-term customer value.

View recap

GXO Logistics, Inc.

GXO Q2 2026

Reported: 2026-08-08

Shares fell 10.2% following the Q2 report as investors reacted negatively to cautious margin outlook and the lack of clear margin expansion despite solid revenue growth and strong new business wins.

Key takeaways

Revenue reached $3.4 billion, growing organically by 3.4% with contributions across all regions.
Adjusted EBITDA was $219 million, with adjusted EPS at $0.59, reflecting stable but pressured profitability.
New business wins totaled $410 million, up over 30% year-over-year, highlighting strong commercial momentum.
Sales pipeline expanded to $2.7 billion post-quarter, supported by growth in strategic verticals like aerospace, defense, and data centers.
Operational improvements and technology investments aimed at margin expansion are in early phases, with meaningful efficiency gains still to materialize.

View recap

Harvia Oyj

HARVIA.HE Q2 2026

Reported: 2026-08-08

The 4.9% stock gain reflects investor approval of strong organic revenue growth and market share gains in North America, which more than offset near-term profit pressure from significant IT and process upgrades causing postponed deliveries and margin mix shifts.

Key takeaways

Q2 revenue rose 11.7% to EUR 52.8 million, all organic, led by a 40% surge in North American sales, particularly sauna cabins.
Adjusted operating profit declined to EUR 8.6 million, or 16.2% of revenue, down from typical margins due to EUR 4 million of postponed deliveries tied to IT/system upgrades.
One-off costs related to the IT and process upgrade, including additional support and overtime, also weighed on profitability.
Growth was dampened in heater-heavy regions (Northern Europe, Continental Europe, APAC, and Middle East), partially impacted by geopolitical uncertainty in the Gulf, affecting about 1% of growth.
Capital investments continued, focusing on expanding North American factory capacity and digital product innovation, aiming to support scalable long-term growth.

View recap

The Honest Company Inc. Common Stock

HNST Q2 2026

Reported: 2026-08-08

The Honest Company’s shares surged 39.3% following Q2 results that notably outperformed expectations, driven primarily by impressive top-line growth and substantial margin expansion.

Key takeaways

Organic revenue increased nearly 7%, supported by consumption growth of approximately 8%, both significantly outpacing respective category growth.
Adjusted gross margins reached a record 43.8%, with adjusted EBITDA margins at 9.8%, reflecting strong operational efficiency.
Wipes segment momentum was a standout, with total wipes consumption up 26% versus 2% in the category; flushable wipes grew more than 200%.
Personal care sales rose 19%, substantially ahead of the category growth of 5%, indicating successful brand penetration.
Household penetration improved 100 basis points to 8.1%, with two-thirds of this growth from households without children, broadening the brand’s appeal.

View recap

Heritage Insurance Holdings, Inc.

HRTG Q2 2026

Reported: 2026-08-08

Shares rose 8.3% following earnings as Heritage demonstrated improved underwriting discipline, accelerating personal residential new business production, and a more diversified platform driving confidence in sustainable growth.

Key takeaways

Reported record net income of $61.7 million and diluted EPS of $2.05, reflecting strengthened profitability.
Annualized return on equity exceeded 45%, supported by disciplined capital allocation and underwriting.
Operating cash flow remained substantial at $166.5 million, underpinning financial strength.
Policy count declines moderated with positive trends in reopened territories, indicating an approaching inflection point towards growth.
Guidewire platform implementation temporarily slowed new business production, but agent feedback is overwhelmingly positive, supporting future efficiency gains.

View recap

Installed Building Products, Inc.

IBP Q2 2026

Reported: 2026-08-08

Installed Building Products' shares rose modestly by 1.1% following a quarter that reflected continued headwinds in new residential volume and margin pressure from higher fuel and medical costs, while commercial strength and acquisitions partially offset weaknesses. The market’s tepid reaction suggests investors view results as mixed, with limited upside from guidance or outlook.

Key takeaways

Consolidated revenue increased 2% to $778 million, driven by acquisitions and commercial end-market growth despite a 5% volume decline primarily in new single-family residential.
Same-branch sales fell less than 1% overall, with a 6% decline in new residential offset by a 10% rise in commercial installation sales and robust multifamily backlog growth.
Adjusted gross margin contracted 90 basis points to 33.3%, with installation segment margin down 60 basis points to 36.5%, pressured largely by a 50-basis point fuel cost increase.
Selling and administrative expenses rose 3%, including a 30-basis point negative impact on EBITDA margin from higher medical insurance costs.
The company completed acquisitions adding ~$30 million in annual revenue, maintaining an optimistic pipeline targeting $100 million for 2026 despite ongoing residential sector challenges.

View recap

Infineon Technologies AG

IFX.DE Q3 2026

Reported: 2026-08-08

Infineon’s shares fell 5.3% post-earnings as the market reacted negatively to a cautious outlook coupled with margin pressure in the Green Industrial Power segment and signs of operational headwinds despite solid revenue growth.

Key takeaways

Q3 revenue grew 9% sequentially to a record €4.172 billion, driven by strong demand in automotive and AI-related infrastructure segments.
Segment earnings margin improved to 19.1% overall, supported by volume and mix, but the Green Industrial Power unit’s margin dropped from 11.7% to 9.8% due to temporary operational and inventory issues.
Automotive segment sales increased 6% to €1.932 billion with a margin of 18.4%, though ongoing transition costs are expected to weigh on profitability this fiscal year.
Order backlog rose markedly to nearly €30 billion, signaling strengthening demand, but increased costs and cautious commentary on near-term profitability tempered investor enthusiasm.
Free cash flow notably turned positive to €599 million from a negative €63 million last quarter, driven by improved operating profit, but concerns remain over margin sustainability.

View recap

indie Semiconductor, Inc.

INDI Q2 2026

Reported: 2026-08-08

Indie’s Q2 results impressed investors, driving a +19.2% stock jump, fueled primarily by broad-based revenue growth and strong momentum in high-potential segments such as radar chipsets and photonics.

Key takeaways

Revenue grew 24% year-over-year to $64 million, exceeding the midpoint of guidance.
Radar chipset solutions gained significant traction, including a new design win with a leading Tier 1 supplier supporting Volvo, underpinning expected production ramp.
The company is leveraging its unique 120 GHz radar technology, which has been evaluated positively by Tier 1s and OEMs for physical AI applications beyond automotive.
Photonics segment accelerated, marked by a record quarter in Quantum bookings and increased demand for optical fiber components tied to AI and security infrastructure.
Long-term market tailwinds remain robust, with high-growth projections in automotive radar and quantum photonics supporting indie’s diversified growth outlook.

View recap

IonQ Inc. Common Stock

IONQ Q2 2026

Reported: 2026-08-08

IonQ’s shares fell 4.8% following the earnings release, driven by investor concerns around cautious forward guidance and margin pressure despite strong revenue growth and technological milestones.

Key takeaways

Revenue reached $80.1 million in Q2 2026, up 287% year-over-year, marking a new company record.
The acquisition of SkyWater was completed, creating a vertically integrated quantum platform spanning design, fabrication, and deployment.
Progress on semiconductor-based quantum chips continued with first fully integrated QPUs now undergoing testing, advancing IonQ’s roadmap to 256-qubit systems targeted for 2027.
Technical validation included industry-first demonstration of breakeven quantum error correction using qLDPC codes, underscoring IonQ’s innovation lead.
Despite these achievements, investors reacted negatively, likely reflecting cautious management outlook or margin compression referenced implicitly in the call.

View recap

Inter Parfums, Inc.

IPAR Q2 2026

Reported: 2026-08-08

Shares fell 7.4% following a miss on growth expectations, with investors likely disappointed by broad deceleration in key regions, ongoing Middle East headwinds, and uneven brand momentum despite some bright spots.

Key takeaways

Consolidated sales grew 2% in Q2 and the first half, but growth was uneven across regions: Asia Pacific (+14%) and South America (+15%) offset declines in Middle East (-24%), Eastern Europe (-7%), and Western Europe (-3%).
North America posted a moderate 5% gain, benefiting from new product extensions in Coach and sustained marketing investments.
Several flagship brands showed mixed results: Ferragamo surged 41% in Q2 (17% H1), Jimmy Choo jumped 23% in Q2, while Lacoste fell 16% year-over-year amid tough comps and regional weakness.
Ongoing geopolitical challenges in the Middle East heavily weighed on overall results, particularly impacting Cavalli's largest market in the region.
Management highlighted solid execution and a confident outlook, but the stock’s sharp drop signals investor skepticism about near-term growth and margin sustainability.

View recap

Ironwood Pharmaceuticals, Inc.

IRWD Q2 2026

Reported: 2026-08-08

Ironwood's shares gained 4.1% following a strong LINZESS performance that drove raised full-year guidance, supported by both demand growth and improved pricing, while advancing apraglutide development and maintaining solid profitability.

Key takeaways

LINZESS U.S. net sales reached $282.3 million in Q2, up 14% year-over-year, powered by mid-single-digit prescription demand growth and improved net pricing.
First half LINZESS net sales totaled $555 million, a 44% increase year-over-year, contributing to raised full-year 2026 financial guidance.
The FDA approved LINZESS for pediatric functional constipation, extending the drug’s market exclusivity and addressing new patient segments.
Apraglutide Phase III STARS-2 trial officially initiated, with patient recruitment underway to confirm earlier positive data.
Q2 financials included $51.3 million GAAP net income and $83 million adjusted EBITDA, with repayment of $200 million convertible notes, positioning the company for further debt reduction and sustained cash flow generation.

View recap

KBC Group NV

KBC.BR Q2 2026

Reported: 2026-08-08

KBC's stock was largely unchanged, edging up 0.2% post-earnings as the second quarter showed steady performance with controlled costs and solid loan growth, though tempered by significant one-off impairment charges and cautious commentary on credit cost ratios and segment impacts.

Key takeaways

Reported net profit reached EUR 1,152 million with a return on tangible equity of 18%.
Customer loan volumes grew 2.8% in the quarter, raising year-to-date growth to 4.3%, prompting an increase in full-year loan growth guidance to at least 6%.
Net interest income of EUR 1,805 million benefited from higher yields, deposit inflows, and increased lending income (up EUR 28 million).
Recorded a EUR 42 million impairment related to the removal of mortgage interest rate caps in Hungary, a significant one-off affecting the quarter.
Operating costs remained well controlled and aligned with guidance, supported by digital initiatives like AI-powered Kate, which is driving customer engagement and sales.

View recap

Kimberly-Clark Corporation

KMB Q2 2026

Reported: 2026-08-08

Kimberly-Clark’s shares fell 2.4% after earnings as the market reacted to lower-than-expected organic sales growth, primarily due to disruption in the China diaper business and trade inventory reduction in North America. Despite solid profit and EPS performance aided by a tariff refund, concerns around growth deceleration and ongoing China uncertainty weighed on sentiment.

Key takeaways

Organic sales growth in Q2 missed expectations by approximately 100 basis points, driven by China diaper disruption late in the quarter and North American trade inventory destocking.
Category growth softened to around 2%, below earlier assumptions of 2.5%, signaling a tougher consumer backdrop.
Adjusted operating profit and EPS benefited from a tariff refund, supporting better-than-expected profitability despite top-line pressures.
The China market remains a significant headwind with sellout stabilizing but not improving amid ongoing reputational challenges and consumer caution.
Management cautioned that while brand fundamentals remain intact, the near-term outlook is tempered by discrete issues and moderating category growth.

View recap

Kemper Corporation

KMPR Q2 2026

Reported: 2026-08-08

Kemper's shares dropped 2.6% following the quarter as investor concerns linger around continued challenges in personal auto, particularly in California, and caution around growth priorities amid ongoing efforts to restore profitability. Despite sequential operational improvements, the stock reaction reflects skepticism toward the path and pace of recovery.

Key takeaways

Reported GAAP results were significantly affected by a goodwill impairment, contributing to a $464.8 million net loss or $7.90 per share.
Adjusted consolidated net operating income was $26.3 million or $0.45 per share, reflecting sequential improvement driven by P&C underwriting and expense management.
Personal auto remains a drag, with returns below targets due to high concentration in California; management is taking actions but results will require time to improve.
Commercial auto showed strong underlying performance, but management plans to prioritize disciplined underwriting and rate increases to maintain profitability even at the expense of growth.
Life segment delivered stable earnings and cash flow, supporting the company’s diversification strategy amidst broader operational challenges.

View recap

Klaviyo, Inc.

KVYO Q2 2026

Reported: 2026-08-08

Klaviyo’s shares dropped 12.4% following earnings, driven primarily by investor concerns around deceleration and cautious outlook despite ongoing product innovation and customer growth.

Key takeaways

Revenue grew 26% year-over-year, reaching a $1.5 billion annualized run rate.
The company signed its largest-ever 8-figure multiproduct deal with a fast-growing e-commerce brand.
Marketing analytics ARR grew over 100% year-over-year but did not offset concerns on overall business momentum.
User engagement with the new Composer agent is encouraging, with 95,000 users in the first month and nearly 25% weekly recurring usage.
Management emphasized AI-driven platform enhancements and infrastructure scalability, yet the market evidently found the outlook or pace of growth insufficient.

View recap

Lamar Advertising Company (REIT)

LAMR Q2 2026

Reported: 2026-08-08

Shares in Lamar edged up 1.7% after reporting steady second-quarter growth, with revenue and EBITDA advancing alongside margin expansion. However, the modest market reaction suggests investors are cautiously digesting the results without meaningful upside surprises.

Key takeaways

Acquisition-adjusted revenue increased 6.1% year-over-year, driven by gains across all business segments and geographies.
Adjusted EBITDA grew 7.3% on an acquisition-adjusted basis, reaching a record margin of 49.2%, the highest in company history.
Digital revenue rose 15.4% YoY, making up one-third of total billboard revenue, with programmatic sales surging over 50%.
National and programmatic revenue increased nearly 16%, supported by the World Cup and anticipated midterm election spending.
Expenses rose 5.1%, 150 basis points above expectations, due to higher variable costs linked to revenue growth.

View recap

nLIGHT, Inc.

LASR Q2 2026

Reported: 2026-08-08

Shares plunged 25.4% following earnings as investors reacted negatively to cautious commentary on supply chain challenges and a tempered outlook, which overshadowed solid revenue growth and a record backlog.

Key takeaways

Revenue hit a record $82.6 million, up 34% year-over-year, driven by product sales growth of 45%.
Adjusted EBITDA reached a solid $11 million, with cash from operations at a record $21 million.
The company highlighted ongoing supply chain constraints and export control impacts, suggesting potential headwinds ahead.
While the recent $600 million Department of War JLWS contract underlines strategic positioning, management cautioned on near-term execution risks.
Strong defense market demand is balanced by lingering operational uncertainties, prompting investor concern reflected in the sharp stock selloff.

View recap

L Brands, Inc.

LB Q2 2026

Reported: 2026-08-08

LandBridge’s stock edged down 0.3% as the market took a neutral stance on the Q2 results that showed solid revenue and EBITDA growth but no change in guidance, signaling no new upside to propel shares higher. Key Takeaways:

Key takeaways

Q2 revenue reached a record $66.8 million, up 41% year-over-year and 31% sequentially, supported by strong activity across surface use royalties, resource sales, and oil and gas royalties.
Adjusted EBITDA was $59.8 million, growing 41% year-over-year and 33% sequentially, with margins steady at 89%.
Free cash flow was $40.2 million, increasing 11% year-over-year, maintaining a 60% free cash flow margin.
Oil and gas royalties contributed only about 5% of total revenues, limiting commodity price exposure despite a 20% sequential increase in this segment.
Full-year 2026 guidance was reaffirmed, with no upward revision, possibly tempering investor enthusiasm given recent performance.

View recap

Leef Brands Inc.

LEEEF Q2 2026

Reported: 2026-08-08

Shares dropped 10.2% as investors reacted negatively to a noticeable revenue deceleration driven by a temporary biomass supply gap, resulting in lower extraction yields, margin pressure, and weaker Q2 volumes despite some margin improvement.

Key takeaways

Revenue declined 16% year-over-year to $7.3 million due to exhausted own-cultivated biomass and reliance on higher-cost, lower-quality third-party material.
Adjusted EBITDA was negative $631,000 in Q2, weighed down by the shift away from vertically integrated input material.
Gross profit rose 62% to $2.4 million, with gross margins improving to 33% from 17% a year ago, reflecting a favorable product mix shift toward higher-margin hydrocarbon products.
Volumes declined approximately 20%, with management intentionally limiting third-party biomass purchases to protect margins ahead of their larger harvest later in the year.
The balance sheet strengthened with $5 million cash and $7.1 million inventory growth, positioning the company to capitalize on the upcoming harvest and restore margin profile in H2 2026.

View recap

Centrus Energy Corp.

LEU Q2 2026

Reported: 2026-08-08

Centrus shares rose modestly by 2.0% following Q2 results that showed steady execution and growing backlog but lacked a clear catalyst to drive a stronger market response.

Key takeaways

Reported Q2 revenue of $176.1 million with gross profit of $49.9 million and operating income of $10.4 million.
Adjusted net income was $38.7 million, translating to adjusted diluted EPS of $1.77.
Backlog grew to $4.5 billion, with $3.7 billion from LEU and $0.8 billion from Technical Solutions segments, reflecting solid order momentum.
Signed a $900 million DOE task order supporting commercial-scale production capacity expansion, marking a key transition from demonstration to commercial readiness.
Completed HALEU production requirements under the DOE contract two weeks ahead of schedule, with near-term plans to commercialize existing HALEU cascade operations.

View recap

LifeStance Health Group Inc. Common Stock

LFST Q2 2026

Reported: 2026-08-08

LifeStance Health’s Q2 results surpassed expectations, driving a 4.5% stock increase as revenue growth, clinician productivity, and margin expansion outpaced projections.

Key takeaways

Revenue grew 26% year-over-year to $435 million, led by 19% higher visit volumes and a 6% rise in revenue per visit.
Clinician base increased 11% to 8,542, with visits per clinician up 7%, sustaining strong productivity gains.
Adjusted EBITDA nearly doubled, rising 94% to $66 million, lifting EBITDA margin by over 500 basis points to 15.2%.
Center Margin improved 41% to $153 million, reaching 35.2% of revenue, driven primarily by revenue strength.
Free cash flow of $88 million reflects solid collections and favorable payroll timing, supporting a healthy balance sheet with $226 million in cash.

View recap

Cheniere Energy, Inc.

LNG Q2 2026

Reported: 2026-08-08

Cheniere's shares rose modestly by 0.5% following Q2 earnings, reflecting results broadly in line with expectations as the company delivered steady operational execution and maintained upward guidance, but without a market-pleasing catalyst to drive a stronger move.

Key takeaways

Reported consolidated adjusted EBITDA of approximately $1.8 billion and distributable cash flow (DCF) of about $1.2 billion in Q2.
Production and exports increased 20% year-over-year, with 184 cargoes totaling 672 TBtu, supported by accelerated start-up of additional Stage 3 trains and improved operational reliability.
Full year 2026 guidance was raised again, now targeting $7.9–8.4 billion EBITDA and $5.3–5.8 billion DCF, driven by improved production forecasts, higher marketing margins, and optimization gains.
Continued share repurchases with approximately 2.2 million shares bought back for $550 million, funded alongside $1.1 billion growth capital expenditures.
Progress on growth projects remains on track, with Stage 3 at over 98% completion and substantial progress on mid-scale Trains 8 and 9 and the Sabine Pass expansion moving forward with a key Bechtel contract signed.

View recap

Loar Holdings Inc.

LOAR Q2 2026

Reported: 2026-08-08

Loar Holdings shares dropped 6.3% following the earnings release, reflecting investor disappointment likely tied to cautious commentary on new business pipeline conversion and continued sales variability despite record quarterly results.

Key takeaways

Reported a 16th consecutive quarter of sequential adjusted EBITDA growth, with record sales and adjusted EBITDA margins exceeding 40%.
Commercial OE segment saw a remarkable 28% sales increase, driven by Boeing 787, A320 family, and 737 platforms.
Defense segment sales improved 8% year-over-year but remain subject to expected quarterly volatility.
New business pipeline conversion stood at approximately 25%, below internal expectations, with ongoing efforts to develop remaining opportunities.
Updated 2026 adjusted EBITDA guidance to $265 million–$270 million, reflecting confidence but tempered by a cautious outlook on near-term pipeline visibility.

View recap

LTC Properties, Inc.

LTC Q2 2026

Reported: 2026-08-08

LTC Properties’ shares rose modestly by 2.9% following Q2 results that showed progress on their SHOP acquisition strategy and portfolio transformation, but the market reaction signals tempered enthusiasm, likely reflecting cautious sentiment on execution risks or incremental guidance improvements that fell short of driving a stronger move.

Key takeaways

The company increased 2026 SHOP acquisition guidance by 50% to $900 million at the midpoint, with $700 million closed by the end of September.
Proceeds from dispositions and loan payoffs are expected at $730 million in 2026, $465 million above prior guidance, with a favorable blended cap rate of 7.3%.
SHOP is now projected to represent 40% of pro forma annualized NOI by the end of September, ahead of previous timing expectations, targeting 50% by year-end 2026.
Core SHOP NOI showed incremental growth from $12.7 million in Q1 to $13.3 million in Q2, with an anticipated 14% pro forma growth rate for SHOP in 2026 versus 2025.
The credit facility was expanded to $900 million, providing additional liquidity to support growth; however, management’s cautious tone on timing of loan payoffs and disposition execution suggests potential near-term headwinds.

View recap

Marathon Digital Holdings, Inc.

MARA Q2 2026

Reported: 2026-08-08

Shares fell 10.2% as investors reacted negatively to cautious outlook signals and the absence of clear near-term growth catalysts despite the company's strategic asset acquisitions and capacity expansion efforts.

Key takeaways

The company announced acquisitions expanding its power portfolio to approximately 4.8 GW, more than doubling current capacity, positioning it as a leading powered landowner in the digital infrastructure space.
Strategic transactions such as the Long Ridge acquisition and Matagorda County site are expected to enhance earnings and support long-term AI infrastructure growth.
The shift from hosted mining towards wholly owned capacity aims to improve unit economics and operational control over time.
Management emphasized supply constraints in power-ready sites amid accelerating demand for AI infrastructure, underscoring the strategic value of their energized assets.
Despite these strategic moves, the cautious tone around near-term outlook and absence of immediate concrete growth drivers weighed on investor sentiment.

View recap

MetLife, Inc.

MET Q2 2026

Reported: 2026-08-08

MetLife's stock edged up modestly by 1.6%, reflecting steady execution but lacking a clear catalyst to drive stronger investor enthusiasm amid mixed segment performance and cautious outlook signals.

Key takeaways

Adjusted earnings rose 15% year-over-year to approximately $1.6 billion, with EPS growth at 20%, supported by disciplined capital management.
Group Benefits segment delivered a 25% increase in adjusted earnings, driven by favorable life underwriting and improved mortality ratios.
Retirement and Income Solutions saw modest adjusted earnings growth of 2%, with adjusted PFOs rising 19%, highlighting selective capital deployment in global markets.
Asia operations reported a 21% increase in adjusted earnings (25% on a constant currency basis) and 17% sales growth, led by momentum in Korea and A&H product innovation in Japan.
Despite integration headwinds from PineBridge Investments raising expenses by ~50 bps, the direct expense ratio held steady at 12.1%, supported by AI-driven productivity gains.

View recap

Manulife Financial Corporation

MFC.TO Q2 2026

Reported: 2026-08-08

Shares declined 1.1% following the release of second quarter results, reflecting investor caution despite solid sales growth and profitability gains. The market appears to be weighing insurance experience headwinds in Canada and the U.S. alongside mixed segment performance.

Key takeaways

Annual Premium Equivalent (APE) sales increased 21% year-over-year, driven by broad-based double-digit growth across all regions, particularly strong momentum in Asia.
New business Contractual Service Margin (CSM) grew 16% YoY, contributing to an overall CSM balance increase of 20%, supporting future earnings potential.
Core Earnings Per Share (EPS) rose 16%, fueled by 12% core earnings growth and share buybacks, with Asia leading (+21%) and Global WAM up 9% despite eMPF transition impacts.
Insurance experience was weaker in Canada and the U.S., dampening overall profitability despite the group’s diversified business model.
The balance sheet remained strong with a LICAT ratio of 136% and conservative leverage, providing capital flexibility for dividends and buybacks.

View recap

Maximus, Inc.

MMS Q3 2026

Reported: 2026-08-08

Shares fell 6.3% as investors reacted negatively to a cautionary outlook driven by a customer-directed pause in performance incentives on Maximus’ VA Medical Disability Exam program, which is set to weigh on fourth quarter profitability and margins.

Key takeaways

Q3 revenue of $1.28 billion met expectations but reflected a pullback from prior-year temporary surges in natural disaster support and clinical volumes, particularly impacting the U.S. Federal Services segment.
Adjusted EBITDA margin improved slightly to 15.0% from 14.7% year-over-year, reflecting operational efficiencies rather than volume growth.
U.S. Federal Services operating margin rose to 18.6% despite revenue challenges; however, a pause in incentives on the VA MDE contract will pressure margins starting Q4.
U.S. Services revenue held steady at $418 million, with a positive growth outlook for Q4 driven by Medicaid-related state engagements.
Operating cash flow was negative $125 million, with elevated DSO of 98 days due to administrative delays at a key federal customer, though collections have begun to improve in July.

View recap

Everspin Technologies, Inc.

MRAM Q2 2026

Reported: 2026-08-08

Shares of Everspin Technologies declined 10.2% following Q2 results, driven by cautious outlook concerns and the winding down of a key DoD sustainment contract, which weighed on investor sentiment despite strong product revenue growth.

Key takeaways

Q2 revenue reached $18.7 million, marking the highest quarter in company history, supported by a $40 million agreement with a U.S. prime contractor.
Product revenue grew 38% year-over-year and 9% sequentially, fueled by strength in industrial automation, energy management, and aerospace and defense sectors.
The $14.6 million DoD sustainment contract began winding down, contributing only $0.5 million in other income this quarter, with expected completion in H1 2027.
Product pipeline advances include the upcoming 256-megabit xSPI tape-out and customer availability of high-reliability 128-megabit and 256-megabit xSPI parts ahead of schedule.
Ongoing development projects target expansion into data center markets with CXL interface-based MRAM solutions, aiming to improve compute efficiency and expand total addressable market.

View recap

Matador Resources Company

MTDR Q2 2026

Reported: 2026-08-08

Matador shares rose 4.3% following Q2 as the company delivered near-record free cash flow and exceeded the high end of its production guidance, reassuring investors with strong operational execution and continued progress on substantial debt reduction.

Key takeaways

Adjusted free cash flow reached $303 million in the quarter, enabling $200 million of bank debt repayment tied to the federal lease acquisition.
Production exceeded the high end of guidance, supported by a 5% increase in reserves, which rose from 667 million to 703 million BOE.
The company emphasized ongoing debt reduction with total borrowings now below $1 billion and a potential $900 million free cash flow forecast for the full year.
Strategic acquisitions including Cardinal, Paloma, and Ridge Runner properties expanded the asset base, particularly in New Mexico, with smooth integration of the Cardinal team.
Midstream-assets financing maintained discipline by segregating funding sources; Cardinal midstream cash flows are expected to complement Matador’s existing pipeline systems and support upstream operations.

View recap

McEwen Mining Inc.

MUX Q2 2026

Reported: 2026-08-08

Shares declined 2.6% as investors reacted to operational setbacks at Gold Bar, including lower production and recovery issues caused by unexpected carbonaceous ore, along with persistently high costs and the absence of near-term fixes.

Key takeaways

Production at Gold Bar was below plan due to carbonaceous ore impacting gold recovery rates.
Costs remained elevated, contributing to margin pressure for the quarter.
Management acknowledged execution shortcomings and outlined ongoing technical and geological adjustments to address recovery challenges.
Exploration programs continue to show potential for resource expansion at the Fox Complex.
Advancement of the Los Azules copper project remains a strategic priority but does not offset current operational disappointments.

View recap

Rubis

NDA.DE Q3 2026

Reported: 2026-08-08

The stock dropped 9.4% as investors reacted negatively to a cautious outlook masked by persistent margin pressure from declining concentrate treatment charges and a sharp inventory-driven cash flow deficit, undermining confidence despite reported earnings growth.

Key takeaways

Operating EBT rose 31% year-over-year to EUR 374 million for the first nine months and 23% sequentially in Q3, reflecting improved metal prices and operational performance.
Net cash flow turned sharply negative to minus EUR 28 million YTD and minus EUR 189 million in Q3, primarily due to a substantial buildup of intermediate product inventories required for ramping up expansion projects.
Free cash flow before dividends remained deeply negative at minus EUR 365 million, worsening from minus EUR 211 million last year, with break-even expected only by fiscal year-end.
Gross margin increased by EUR 140 million to about EUR 1.7 billion, supported by higher metal prices and volumes; however, the share of lower-margin concentrate treatment charges declined significantly.
The tight concentrate market continues to weigh on revenue quality, with spot TC/RCs falling further and pressuring segment profitability despite favorable metal price trends and strong sulfuric acid pricing.

View recap

NN Group N.V.

NN.AS Q2 2026

Reported: 2026-08-08

NN Group’s shares declined modestly by 0.7% following H1 2026 results, reflecting a market view that solid top-line growth and operational progress were tempered by underlying challenges in Japan’s life insurance segment and a cautious outlook on competitive pressures.

Key takeaways

Operating capital generation (OCG) increased 5% year-over-year to EUR 1.1 billion, above the flat guidance given.
Group solvency ratio improved to 224% after excluding banking operations, providing a clearer capital position.
Value of new business (VNB) rose 16%, with European growth (+14%) led by risk protection products; however, VNB in Japan declined due to shifting customer preferences and increased market competition.
Non-life gross written premiums grew by 6%, and Dutch defined contribution assets under management increased by 13% to EUR 48 billion.
Future Ready program achieved 65% of targeted annual cost savings ahead of schedule, supporting efficiency and AI adoption without additional investment needs.

View recap

National Retail Properties, Inc.

NNN Q2 2026

Reported: 2026-08-08

NNN REIT’s shares edged down 0.4% following Q2 results that reflected stable operational performance without notable upside or downside surprises, aligning with market expectations.

Key takeaways

AFFO was $0.90 per share, up 5.9% year-over-year, supported by lower-than-expected bad debt of 2 basis points of ABR.
Portfolio occupancy rose to 99.1%, an increase of 50 basis points sequentially and 110 basis points year-over-year, driving NOI margin to 96.6%, up 70 basis points from Q1.
Acquisitions totaled $290 million in 89 properties with stable cap rates of 7.3% and an average lease duration of nearly 18 years; full-year acquisition guidance raised to $750 million from $600 million.
Dispositions included 26 properties generating $37 million, focusing on non-core assets sold at cap rates 170 basis points below acquisition levels; disposition guidance lifted to a midpoint of $140 million.
Balance sheet remains strong with $1.4 billion liquidity and debt maturity of 10.1 years, maintaining financial flexibility for growth and capital deployment.

View recap

Nutrien Ltd.

NTR Q2 2026

Reported: 2026-08-08

Nutrien’s shares fell 3.7% after the earnings release, primarily driven by cautious nitrogen market outlook and deceleration in global urea prices during a seasonally weak demand period exacerbated by geopolitical uncertainty.

Key takeaways

Adjusted EBITDA reached $2.4 billion in Q2 and $3.5 billion in H1 2026, up 6% year-over-year.
Potash volumes hit record levels, with controllable cash costs flat YoY and automation enabling cost discipline.
Proprietary crop nutrients gross margin grew 10%, supported by targeted capacity expansions despite softer overall fertilizer demand.
Nitrogen segment faced price softness in Q2 due to seasonal factors and geopolitical disruptions, though the North American assets remain cost advantaged.
Continued portfolio optimization with $1 billion in gross proceeds generated from asset divestitures since late 2024; strategic reviews underway for phosphate and other segments.

View recap

Natera, Inc.

NTRA Q2 2026

Reported: 2026-08-08

Natera’s +17.3% stock jump reflects strong revenue growth driven by record test volumes and an upward revision to full-year guidance, underscoring sustained momentum in oncology, particularly Signatera’s notable FDA and PMDA milestones.

Key takeaways

Recorded approximately 1.044 million tests processed in Q2, exceeding 1 million for the first time and marking a company record.
Clinical MRD oncology units grew 56% year-over-year to 283,000, with the largest sequential increase to date (+34,000 units vs Q1).
Q2 revenue reached ~$753 million, up ~38% year-over-year and ~40% excluding revenue true-ups, with gross margins improving to ~65%.
Raised full-year revenue guidance midpoint by $100 million to a range of $2.85 billion–$2.91 billion, implying 31% revenue growth ex true-ups.
Signatera achieved several key regulatory and clinical milestones, including first US FDA MRD companion diagnostic approval, Japanese PMDA approval, and NCCN Category 1 recommendation for muscle invasive bladder cancer.

View recap

Nexstar Media Group, Inc.

NXST Q2 2026

Reported: 2026-08-08

Nexstar shares rose modestly, up 2%, reflecting a generally stable view of the quarter’s results amid execution on the TEGNA acquisition and solid advertising revenue, though the market did not respond with enthusiasm likely due to ongoing litigation and cautious outlook factors.

Key takeaways

Reported record quarterly revenue of $2 billion and adjusted EBITDA of $633 million, driven notably by the TEGNA acquisition.
Free cash flow more than doubled year-over-year to $238 million for the quarter, signaling improved operational cash generation.
Advertising revenues were supported by strong midterm political advertising, FIFA World Cup sports advertising, and legacy local streaming growth.
Continued cost efficiencies through centralizing marketing, content automation, and sales incentive realignment helped margins.
Ongoing legal and regulatory challenges related to the TEGNA acquisition remain active, including upcoming appellate and district court proceedings.

View recap

Blue Owl Capital Corporation

OBDC Q2 2026

Reported: 2026-08-08

Blue Owl Capital’s shares rose 6.1% following the quarter as investors responded positively to steady net investment income growth, a supportive dividend framework, and improved financial flexibility despite a modest NAV decline driven by a single credit markdown.

Key takeaways

Adjusted net investment income (NII) per share was $0.34, supporting a 9.6% annualized return on equity, up over 100 basis points sequentially.
The company declared a $0.02 per share supplemental dividend on top of the recently reset base dividend, reflecting earnings above the baseline.
Net asset value per share declined modestly, primarily due to one credit-specific markdown, with broader portfolio marks remaining stable.
Net leverage fell to 1.11x, the lowest in over two years, driven by healthy repayments exceeding new fundings and active share repurchases totaling $35 million.
Transaction activity remained cautious amid macro uncertainty, but realizations like the full repayment of the Mavis Tire investment, generating a 1.5x multiple on invested capital and reducing PIK exposure, boosted income and underscored disciplined capital deployment.

View recap

OceanaGold Corporation

OGC.TO Q2 2026

Reported: 2026-08-08

Oceana Gold's Q2 performance exceeded expectations, driving a 3.9% stock gain, led by record adjusted EBITDA margins and strong free cash flow generation. The company advanced key growth projects while maintaining a healthy balance sheet and returning capital to shareholders.

Key takeaways

Gold production reached approximately 139,000 ounces, up 7% sequentially and in line with full-year guidance.
Adjusted EBITDA margin hit a quarterly record of 61%, supported by lower cost of sales and reduced government share at Didipio.
Free cash flow totaled $130 million for the quarter, contributing to $385 million year-to-date and enabling $78 million returned through dividends and buybacks.
Growth capital spending focused on Waihi North and Palomino underground projects, with exploration expenditures significantly increased to support future value creation.
Balance sheet strengthened with cash up 6% to $655 million and zero debt, positioning the company well for continued operational and financial flexibility.

View recap

Omada Health

OMDA Q2 2026

Reported: 2026-08-08

Omada Health’s Q2 earnings drove a +23.9% stock rally, fueled by notable revenue growth, margin expansion, and strong membership gains that clearly outpaced expectations.

Key takeaways

Revenue grew 43% year-over-year, marking a record quarter for the company.
Gross margin expanded significantly by 700 basis points on a GAAP basis to 73%, and by 600 basis points on a non-GAAP basis to 74%.
Membership surged 45% year-over-year to 1.1 million active members, demonstrating strong program adoption.
The company turned profitable with $5 million in net income and $11 million in adjusted EBITDA, reversing losses from the prior year.
Commercial momentum continued with new customer wins across diverse sectors and expansion with a major health plan adding 1.5 million covered lives starting in 2027.

View recap

Onity Group Inc.

ONIT Q2 2026

Reported: 2026-08-08

Onity Group's shares rose 3.5% post-earnings, reflecting investor approval of strong origination volume growth and better-than-expected revenue margins despite ongoing challenges in servicing income and sizeable transaction-related costs.

Key takeaways

Reported double-digit year-over-year revenue growth driven by record origination volumes and higher servicing UPB.
Origination adjusted pretax income increased more than threefold year-over-year, benefiting from improved execution and lower interest rates boosting industry volume.
Servicing adjusted pretax income declined over 60% year-over-year due to an 80% increase in MSR runoff as a result of lower interest rates.
The quarter included $33 million in pretax costs tied to reverse asset sale and legacy subservicing transfer, as well as $24 million of unfavorable asset fair value adjustments.
Management reaffirmed full-year 2026 adjusted ROE guidance at the low end of the range amidst continued market volatility and inflationary pressures.

View recap

Ormat Technologies, Inc.

ORA Q2 2026

Reported: 2026-08-08

Ormat Technologies reported solid revenue growth driven by accelerating momentum across its electricity and energy storage segments, which propelled the shares up 10.3% following earnings.

Key takeaways

Q2 revenue rose 10.6% to $258.8 million, fueled primarily by a 195% jump in energy storage segment revenue and 5.8% growth in electricity segment revenue.
Gross profit increased 20.8% to $68.7 million, lifting consolidated gross margin by 220 basis points to 26.5%, aided by strong storage asset margins.
Adjusted EBITDA increased 6.9% to $143.9 million, reflecting higher contribution from energy storage.
Product segment revenue declined 21.6% to $46.7 million due to timing of manufacturing and construction, with gross margin compressing to 9.7% amid rising costs and FX headwinds.
Company raised full-year revenue and adjusted EBITDA guidance on the back of strong segment performance and ongoing development progress, including key capacity additions.

View recap

Oscar Health, Inc.

OSCR Q2 2026

Reported: 2026-08-08

Oscar Health’s shares fell 7.3% following its second quarter 2026 earnings report, as investors reacted negatively to underlying pressures despite management’s positive framing. The market likely focused on caution around membership trends, deceleration in the ACA individual market, and lack of clarity on sustainable margin expansion amid evolving market dynamics.

Key takeaways

Membership in the ACA individual market declined 12% year-over-year to 19.2 million, indicating ongoing market contraction despite growth in Oscar’s own membership.
Oscar reported 2.96 million members, a 46% increase year-over-year, driven by above-market open enrollment growth and retention in its proprietary plans.
Revenue grew 70% year-over-year to $4.9 billion, but the company did not provide detailed segment profitability or margin guidance that reassured investors.
Medical loss ratio (MLR) improved 12 points to 79.2%, benefiting from moderately favorable utilization and pricing assumptions, though the market remains cautious with limited morbidity data.
Management highlighted technology and AI-driven operational efficiencies, projecting tens of millions in cost savings, but these prospects may not offset concerns about overall market headwinds.

View recap

Occidental Petroleum Corporatio

OXY Q2 2026

Reported: 2026-08-08

Occidental’s shares rose 3.9% following earnings, reflecting investor approval of the company’s progress on sustainable cash flow growth and capital efficiency improvements.

Key takeaways

Principal debt reduced to $11.8 billion, cutting annual interest by approximately $630 million versus 2025.
Quarterly dividend increased by 8% as part of capital return strategy.
Operational efficiencies contributed to a beat in second-quarter production.
On track to surpass $1.2 billion in free cash flow improvement this year, excluding benefits from higher oil prices.
Clear plan set to add over $4 billion in sustainable annual cash flow by 2030 through lower costs, reduced sustaining capital, and balance sheet strength.

View recap

Par Pacific Holdings, Inc.

PARR Q2 2026

Reported: 2026-08-08

Shares dropped 16.9% as investors reacted negatively to the clear deceleration in Hawaii refinery throughput due to an extended turnaround, coupled with disappointing margin capture normalized for price lag and cautious third-quarter throughput guidance.

Key takeaways

Hawaii refinery throughput fell below plan, with June throughput at just 3,000 barrels per day ahead of the plant-wide turnaround starting late June and extending into early August.
Normalized Hawaii margin capture was 99%, below the overall strong segment average, indicating margin compression once price lag effects are excluded.
Mainland refineries delivered solid throughput rates and margin capture, including a record quarterly production in Washington (41.2k bpd at $4.21/boe) and strong Montana capture (144%) supported by favorable product mix and inventory draws.
System-wide adjusted EBITDA rose sharply to $571 million in Q2, driven by elevated market conditions, but investors questioned sustainability given operational disruptions and elevated production costs in Wyoming and Hawaii.
Guidance for Q3 throughput has built-in conservatism, reflecting ongoing turnaround impact in Hawaii and maintenance downtime in Montana, signaling deceleration ahead and pressuring near-term earnings visibility.

View recap

Palladyne AI Corp.

PDYN Q2 2026

Reported: 2026-08-08

The stock was little changed, rising modestly by 0.3% as Palladyne AI reported broad-based revenue growth and stable backlog but offered cautious revenue guidance and flagged elevated cash burn due to one-time expenses and infrastructure build-out.

Key takeaways

Q2 revenues reached a record $5.8 million, up 63% sequentially from $3.5 million.
Backlog increased to approximately $25 million from $17 million in Q1, with about $13 million in new bookings during the quarter.
Full-year 2026 revenue guidance was reiterated at $24 million to $27 million, indicating no upward revision despite growth.
Operating cash burn exceeded prior quarterly averages due to increased business development, nonrecurring capital expenditures, and expanded engineering headcount.
Cash on hand remains solid at approximately $44 million, but expenses reflect the cost of scaling infrastructure ahead of expected revenue contributions.

View recap

Parker-Hannifin Corporation

PH Q4 2026

Reported: 2026-08-08

Parker-Hannifin’s fiscal Q4 and full-year results beat expectations across growth, margins, and earnings, driving a +7.7% stock reaction as investors responded positively to accelerating organic growth and record margin expansion.

Key takeaways

Full-year sales reached a record $21.5 billion, surpassing $20 billion for the first time, with organic growth accelerating to 6.6%.
Adjusted segment operating margin expanded by 120 basis points to a record 27.3%, with Q4 margin hitting 28.0%, the highest ever.
Adjusted EPS increased 18% to a record $32.31 for the year, driven by 21% EPS growth in Q4; quarterly EPS exceeded $9 for the first time.
Operating cash flow set a record at $4.4 billion, surpassing $4 billion for the first time.
The company raised its fiscal 2031 adjusted segment operating margin target to 30%, signaling confidence in continued margin expansion paired with 4%-6% organic growth over the cycle.

View recap

Playtika Holding Corp.

PLTK Q2 2026

Reported: 2026-08-08

Shares fell 24.4% as investors reacted negatively to signs of revenue deceleration, particularly a sequential decline in flagship titles, and a cautious outlook driven by softening consumer demand and a deliberate pullback in marketing spend. Despite margin expansion, investors appeared unconvinced by the sustainability of growth amid lingering headwinds.

Key takeaways

Total revenue declined 1.8% sequentially to $731.1 million but grew 5.0% year-over-year.
Adjusted EBITDA margin improved significantly to 28.2%, up from 16.8% in Q1, driven by reduced marketing spend.
Revenue from top title Bingo Blitz decreased 5.6% sequentially and 9.5% year-over-year, reflecting deeper weakness in recently acquired, less engaged players.
Direct-to-Consumer channel revenues rose 63.1% year-over-year but declined 1.7% sequentially, highlighting mixed traction.
Management signaled caution, citing softer consumer sentiment and inflation pressures as reasons for a measured view on the second half, indicating risk of continued deceleration.

View recap

Power Solutions International, Inc.

PSIX Q2 2026

Reported: 2026-08-08

Shares rallied 24% following a better-than-expected sequential revenue increase of 18.6% and a notable 420 basis point gross margin expansion, reflecting operational improvements at the Wisconsin facility and strong data center demand despite ongoing headwinds.

Key takeaways

Q2 net sales rose 18.6% sequentially to $152.5 million, surpassing prior guidance that expected flat revenue versus Q1.
Gross margin improved materially to 27.1% from 22.9% sequentially, driven by early benefits from capacity ramp-up activities in Wisconsin, partially offset by an unfavorable product mix.
Year-over-year sales declined 21% due to lower shipments in power systems (notably oil & gas softness) and industrial segments.
Operating cash flow enabled a $30.8 million reduction in total debt during the quarter.
Demand for data center power solutions remains strong, with management expecting higher sales in H2 2026, tempered by uncertainties around shipment timing and supply chain variables.

View recap

Peloton Interactive, Inc.

PTON Q4 2026

Reported: 2026-08-08

Peloton's shares plunged 12.9% following the earnings release as investors reacted negatively to a cautious outlook and signs of decelerating engagement, despite ongoing product innovation and modest commercial unit growth.

Key takeaways

Q4 saw a notable increase in Pilates workout engagement, up 44% year-over-year, and workout time increased 53%, highlighting pockets of user activity growth.
The Commercial Business Unit (CBU) delivered double-digit revenue growth in FY '26 and is nearing a 4% share of the commercial fitness equipment market, signaling incremental expansion potential.
Member churn ticked up in Q4 due in part to one-time events, with management expecting churn to remain roughly flat year-over-year in FY '27, indicating persistent retention challenges.
Peloton is investing in retail with a plan to double micro store locations, aiming for a more efficient physical footprint compared to legacy showrooms.
Despite innovations like Peloton IQ and new product launches, management’s outlook hinted at moderated growth and only gradual improvement in churn, which likely dampened investor enthusiasm.

View recap

D-Wave Quantum Inc.

QBTS Q2 2026

Reported: 2026-08-08

Shares fell 2.9% as investors reacted to cautious outlook signals amid an earnings report emphasizing technical progress but lacking clear commercial milestones or updated guidance to drive confidence.

Key takeaways

No guidance update was provided, leaving investors without clarity on near-term revenue or bookings trajectory.
Management emphasized technical differentiation and future potential in quantum error correction but did not disclose concrete commercial adoption metrics.
The focus remained on long-term R&D achievements and architectural advantages rather than near-term financial performance.
Market response suggests skepticism about the timeline and path to meaningful, scalable revenue generation despite technological progress.

View recap

RATIONAL Aktiengesellschaft

RAA.DE Q2 2026

Reported: 2026-08-08

Shares declined 2.4% following the earnings release as investors digested uneven regional growth and ongoing weakness in China, offset only partially by strong performance in Europe and improving margins.

Key takeaways

Group revenues rose 8% organically in H1 2026 to EUR 642 million, with Q2 growth moderating to 4%, partly due to pull-forward effects in the US in Q1.
Europe (excluding Germany) and Germany delivered solid 9% revenue growth, underpinning overall strength in the home market and neighboring regions.
North American revenue grew 4% in H1 but was impacted by timing effects; the underlying organic growth was 10%, with Q3 expected to show further acceleration.
Asia sales declined 2%, driven primarily by a 25% drop in China due to Yum China’s decision to source locally, posing a notable headwind.
EBIT increased 11% to EUR 170 million with margin improvement to 26.5%, supported by U.S. tariff refunds, reflecting cost tailwinds rather than broad-based operational leverage.

View recap

Redwire Corporation Common Stock

RDW Q2 2026

Reported: 2026-08-08

Redwire’s shares jumped 26.8% following Q2 results that demonstrated substantial revenue growth, record backlog, and robust gross margins, all underscoring strong operational execution and favorable demand trends.

Key takeaways

Reported record quarterly revenue of $117.1 million, up 20.7% sequentially and 89.6% year-over-year.
Achieved a book-to-bill ratio of 1.42, driving a record contracted backlog of $542.1 million, supporting forward visibility.
Gross margin reached a new high, contributing to improved profitability metrics.
Strengthened liquidity position with a record $557.8 million in cash, enabling continued investment in growth initiatives.
Expanded capacity with new facilities in Indiana (microgravity research) and Huntsville, Alabama (advanced manufacturing), backed by state incentives.

View recap

Riley Exploration Permian, Inc.

REPX Q2 2026

Reported: 2026-08-08

Shares rose 3.7% following Riley Exploration Permian’s second quarter results, driven by an upward revision to full-year production guidance and operational execution improvements despite midstream constraints that limited near-term upside.

Key takeaways

Q2 oil production approached the high end of guidance, with a June exit rate of 24,400 barrels per day reflecting underlying momentum.
Full-year oil production guidance was increased to approximately 30% year-over-year growth, with expectations for a more than 20% sequential jump in Q3.
Operational activity was the most active in company history, with 19.9 wells drilled and 13.9 turned to sales, supported by record drilling efficiencies including a 19% improvement in lateral footage per day.
Higher capital spend of $87 million, above infrastructure guidance due to accelerated development and pre-funded costs, partly related to delays in third-party infrastructure impacting well turn-ins.
Operating expenses rose $5.4 million sequentially, largely due to $2.3 million of workover spend that added about 700 barrels per day, offsetting cost pressures in inputs through operational efficiencies and vendor optimizations.

View recap

Revolution Medicines, Inc.

RVMD Q2 2026

Reported: 2026-08-08

Shares rose modestly by 2.2% following the quarter, reflecting investor acknowledgment of meaningful progress in pancreatic cancer programs and regulatory milestones, although the reaction suggests some caution remains on near-term commercial ramp or broader pipeline clarity.

Key takeaways

Positive clinical data from the Phase III RASolute 302 trial demonstrated improvements in overall survival, progression-free survival, and quality of life for daraxonrasib in metastatic pancreatic cancer.
The FDA has accepted the new drug application for daraxonrasib, and the EMA has prioritized the drug for accelerated review under its Cancer Medicines Pathfinder initiative.
Expanded access program approved over 90% of requests, delivering daraxonrasib to more than 2,000 patients across nearly all U.S. states and Puerto Rico.
Commercial infrastructure for daraxonrasib’s U.S. launch is fully in place, including sales, medical affairs, and patient services.
Multiple Phase III studies continue enrolling for daraxonrasib and zoldonrasib in first-line and adjuvant pancreatic cancer settings, along with a novel combination trial, supporting a broad development strategy.

View recap

Star Bulk Carriers Corp.

SBLK Q2 2026

Reported: 2026-08-08

Star Bulk Carriers shares rose 3.4% following Q2 results that showcased better-than-expected profitability and balance sheet strength, driven by efficient operations and disciplined capital allocation.

Key takeaways

Adjusted net income was $134.8 million, with adjusted EBITDA of $184.2 million, reflecting strong cash generation capabilities.
Daily time charter equivalent (TCE) averaged $24,486 per vessel, with operating expenses plus cash G&A at $6,542, resulting in a cash margin of approximately $17,944 per vessel per day.
The company maintained a robust liquidity position, ending the quarter with $565 million in cash and $110 million in undrawn revolver capacity.
Capital returned to shareholders remains substantial, highlighted by a $0.90 dividend per share for the quarter and significant debt reduction over recent years.
Fleet investments continue, including five new Kamsarmax vessels expected in 2026, with financing secured and a $56 million mark-to-market gain adding shareholder value.

View recap

Swisscom AG

SCMN.SW Q2 2026

Reported: 2026-08-08

Swisscom's shares rose 4.4% post-Q2 results, reflecting investor approval of faster-than-expected synergy realization in Italy and stronger cost savings in Switzerland, which drove margin expansion and operating free cash flow growth despite ongoing revenue declines.

Key takeaways

Revenue declined 2% year-over-year to CHF 3.6 billion, pressured by lower service revenue in both Switzerland and Italy as well as weaker hardware sales in Italy.
Adjusted EBITDA (EBITDAaL) grew 6.1% to CHF 1.269 billion, supported by synergy gains from the Vodafone Italia integration and effective cost management in Switzerland.
Operating free cash flow surged 23.9% to CHF 608 million, benefiting from 6.3% lower CapEx and improved operational efficiencies.
Swiss B2C mobile net adds were solid (+10,000 RGUs), though broadband RGUs remained negative (-8,000) with efforts underway to stabilize this trend via brand repositioning and selective price increases.
Confirmed full-year guidance signals confidence in execution despite revenue headwinds and continues focus on AI, security, and energy segments for long-term value creation.

View recap

SandRidge Energy, Inc.

SD Q2 2026

Reported: 2026-08-08

SandRidge Energy’s shares rose 3.2% following a quarter marked by production growth, improved revenue, and better-than-expected cash flow generation, signaling investor approval of operational execution and capital discipline despite some commodity price headwinds.

Key takeaways

Production increased 11% year-over-year to 19.7 Mboe per day, driven by a 22% rise in oil volumes.
Revenue rose 48% to just over $51 million, supported by an average oil price of ~$95 per barrel; natural gas realizations declined notably to $1.36 per Mcf from $3.13 due to regional price differentials.
Adjusted EBITDA grew 49% to $34 million, and operating cash flow almost doubled to $42.4 million, underpinning capital expenditure and dividend payments without debt.
Operating expenses and adjusted G&A were moderately higher per BOE but remain controlled relative to production growth.
The company’s hedging program covers about 30% of production midpoint, maintaining downside protection while preserving upside exposure.

View recap

Seaport Entertainment Group Inc

SEG Q2 2026

Reported: 2026-08-08

Seaport Entertainment Group’s shares rose 5.1% after the company reported its first-ever positive operating EBITDA and non-GAAP adjusted net income, driven by strong operational improvements and continued momentum in its events and leasing activities.

Key takeaways

Achieved positive operating EBITDA and non-GAAP adjusted net income for the first time in company history.
Reported a 103% year-over-year improvement in non-GAAP adjusted net income per share in Q2.
Reduced trailing 12-month general and administrative costs by more than 20% to under $27 million.
Leased or programmed roughly 100,000 square feet since spin, leaving less than 50,000 square feet available, with the remaining spaces requiring more detailed negotiations.
Concert business remains strong with 22 shows in Q2, including 13 sellouts and a 91% sell-through rate, alongside increased food and beverage spend per attendee.

View recap

Sweetgreen, Inc.

SG Q2 2026

Reported: 2026-08-08

Sweetgreen shares dropped 11.5% following the quarter as investors reacted negatively to a sharper-than-expected deceleration in comparable restaurant sales and ongoing margin pressure, compounded by a cautious outlook that incorporated uncertainties from recent produce-related health incidents.

Key takeaways

Comparable restaurant sales declined 6.2%, signaling continued traffic weakness despite sequential monthly improvement.
Restaurant-level profit margin contracted to 13.1%, reflecting margin compression amid operational challenges.
Adjusted EBITDA showed a slight loss of $0.2 million, indicating the business is still struggling to return to profitability.
Management highlighted operational improvements and new initiatives like wraps to drive frequency, but these have yet to offset broader sales declines.
The outlook was tempered due to potential impacts from external supply issues, including a cyclospora outbreak (affecting the category) and a jalapeño recall, adding uncertainty to future performance.

View recap

Shoals Technologies Group, Inc.

SHLS Q2 2026

Reported: 2026-08-08

Shoals Technologies' shares fell 7.4% post-earnings as investors reacted negatively to ongoing margin pressure and cautious operational execution despite solid revenue growth and backlog strength.

Key takeaways

Q2 revenue grew 47% year-over-year to $163 million, within guided range; backlog and orders remain healthy with a book-to-bill of 1.3 and backlog at $801 million (+19% YoY).
Adjusted gross margin held steady at 30.6%, but margin improvement remains incremental and subject to operational challenges from factory consolidations and capacity expansion.
SG&A expenses increased, partly from higher payroll and legal costs, limiting operating profit growth to 17% YoY, while GAAP net income declined from prior year due to a one-time gain in 2025.
Adjusted EBITDA grew 28% to $31.6 million, but net debt rose to $181 million with leverage at 1.6x, raising concerns about capital structure amid measured expansion.
Management highlighted progress in manufacturing efficiencies and growth in emerging segments like BESS and international markets, but their cautious tone on operational execution and outlook likely weighed on sentiment.

View recap

Shopify Inc.

SHOP Q2 2026

Reported: 2026-08-08

Shopify's shares surged 19.6% post-earnings, driven by substantial GMV and revenue growth that strongly outpaced typical metrics, underscoring broad-based strength across merchants, geographies, and emerging AI-powered commerce channels.

Key takeaways

Gross Merchandise Volume (GMV) rose 32% to $116 billion, marking the fifth consecutive quarter with GMV growth above 30%.
Revenue increased 34% to $3.6 billion, reflecting broad strength across merchant sizes, geographies, and sales channels.
Free cash flow margin remained healthy at 18%, supporting durability of growth.
AI-driven commerce showed promising momentum, with agentic channel traffic and orders tripling year-over-year and new buyer orders arriving at nearly twice the rate of other channels.
Strategic investments in the Catalog product and Universal Commerce Protocol position Shopify as a critical infrastructure provider for next-generation, AI-enabled commerce experiences.

View recap

Siemens Aktiengesellschaft

SIE.DE Q3 2026

Reported: 2026-08-08

Siemens shares fell 2.2% post-earnings as investor enthusiasm for record orders and revenue growth was tempered by cautious outlook comments and the absence of margin upside beyond expectations.

Key takeaways

Group orders hit a record EUR 27.9 billion, up 14% year-over-year, driving a record backlog of EUR 132 billion.
Revenue growth was broad-based at 8%, with Digital Industries up 9% and Smart Infrastructure exceeding EUR 8 billion in orders.
Industrial Business profit margin stood at 17.3%, supported by tariff refunds; however, no further margin expansion was signaled beyond current levels.
Free cash flow was a solid EUR 4.1 billion, reflecting strong operational execution.
Despite an upgraded full-year earnings outlook, cautious wording on future performance and limited margin guidance likely weighed on shares.

View recap

SharkNinja, Inc.

SN Q2 2026

Reported: 2026-08-08

SharkNinja’s Q2 results outperformed, with a 7.0% stock jump reflecting better-than-expected sales acceleration, broad-based growth, and margin resilience despite tariff pressures.

Key takeaways

Net sales increased over 22% year-over-year, marking the fastest growth since Q4 2024.
Domestic sales grew more than 15%, while international sales surged nearly 37%, led by strong performances in the U.K., Europe, and Latin America.
Gross margin exceeded expectations despite ongoing tariff headwinds, supporting profitability.
Adjusted EBITDA grew nearly 19%, reflecting operating expense leverage.
Adjusted EPS rose nearly 30%, indicating effective earnings compounding alongside sales growth.

View recap

Spotify Technology S.A.

SPOT Q2 2026

Reported: 2026-08-08

Spotify's shares declined modestly by 0.8% post-earnings, reflecting investor caution around the company’s Q3 user metrics and the deliberate introduction of friction in its free service in select emerging markets, which may slow near-term MAU growth despite ongoing revenue acceleration.

Key takeaways

Revenue grew 15% year-over-year on a constant currency basis, slightly accelerating from 14% in Q1.
Gross margin reached a new high of 33.4%, supported by disciplined OpEx and operating margin improvement.
Subscribers surpassed 300 million, beating guidance, with increased engagement measured by active days per global subscriber.
Spotify introduced higher friction in free tiers within emerging markets to boost conversion and monetization, expected to impact Q3 MAU negatively in the near term.
Advertiser metrics improved significantly: active advertisers grew 60% year-over-year, and automated channels now represent nearly 40% of ad-supported revenue, up from 30% in Q1.

View recap

Swiss Re AG

SREN.SW Q2 2026

Reported: 2026-08-08

The stock edged up 1.7% post-earnings, reflecting a broadly in-line performance with mixed signals from pricing pressure in key segments partially offset by strong underwriting results and cost efficiency initiatives.

Key takeaways

Net income of USD 2.8 billion in H1 represents over 60% of the full-year target of USD 4.5 billion, signaling solid progress but not a clear acceleration.
Life & Health Re showed stable in-force margins and positive experience, particularly in U.S. mortality, supporting confidence in the USD 1.7 billion 2026 target.
P&C Re posted strong underwriting results with low natural catastrophe losses (USD 676 million below expectations) and significant reserve releases, though pricing remains challenged with high-single-digit declines in nonproportional property.
Midyear renewals indicated volume growth of 11% but nominal pricing was broadly flat to down mid-single-digit in certain portfolios, highlighting ongoing competitive pressures and cycle management challenges.
Operating cost reduction target was raised to USD 500 million by 2028, reflecting strong early progress and ongoing efficiency efforts, signaling management's focus on structural cost control amid margin headwinds.

View recap

Scholar Rock Holding Corporation

SRRK Q2 2026

Reported: 2026-08-08

Shares rallied 10.5% as Scholar Rock advanced toward the U.S. launch of apitegromab, supported by positive regulatory progress and strong commercial readiness, underpinning confidence in near-term approval and market entry.

Key takeaways

The U.S. BLA for apitegromab was accepted in April with a PDUFA action date of September 30; FDA review is progressing with two fill/finish facilities providing regulatory flexibility.
Significant progress at the second fill/finish facility has resulted in more ready vials than the primary Catalent Indiana site, signaling operational strength.
Commercial preparations for the U.S. launch are well advanced, with the team positioned to launch apitegromab promptly upon approval.
European regulatory interactions continue, with the EMA awaiting FDA inspection outcomes; planning underway for an initial launch in Germany and expansion into a 50-country footprint.
The anti-myostatin clinical pipeline shows active development, including Phase II OPAL and FORGE studies and a Phase I trial of a novel antibody, maintaining momentum beyond apitegromab.

View recap

SUI Group Holdings Limited

SUIG Q2 2026

Reported: 2026-08-08

Shares declined 5.3% as investors reacted negatively to cautious outlook signals and margin pressures embedded in the company’s evolving capital deployment strategy, overshadowing operational progress.

Key takeaways

Network scalability remained strong, sustaining 297,000 transactions per second with 300ms finality, highlighting technical infrastructure capabilities.
Developer engagement grew, with 1,400 developers and a top-10 GitHub activity ranking, pointing to ongoing ecosystem expansion.
Institutional adoption advanced via Coinbase’s direct staking and Mubadala Capital’s tokenized private market strategy, indicating deeper financial product integration.
Treasury deployed additional 4 million SUI tokens to Bluefin, increasing exposure to revenue participation but potentially compressing margins compared to passive staking yield of ~1.7%.
The stock’s 0.72x mNAV valuation implies investor skepticism around balance sheet productivity initiatives and the risk-adjusted returns from strategic lending arrangements.

View recap

Symbotic Inc. Class A Common Stock

SYM Q3 2026

Reported: 2026-08-08

Symbotic’s shares plunged 16.6% following the earnings report, signaling investor disappointment likely driven by a cautious outlook despite top-line growth and margin expansion.

Key takeaways

Revenue reached $721 million, growing 22% year over year and 7% sequentially, driven by 11 new system deployments and a total of 77 systems in deployment.
Operational systems increased to 56, supporting software revenue growth of 57% year over year to $13 million and operations services up 49%.
Gross margin improved sequentially and year over year due to project execution, scale benefits, and favorable revenue mix.
GAAP net income rose to $55 million from a loss of $21 million the prior year’s quarter, with adjusted EBITDA of $95 million exceeding forecast.
Despite these positives, the steep stock drop suggests investors were troubled by management’s cautious tone on future growth or remaining challenges not fully addressed in the report.

View recap

Molson Coors Beverage Company

TAP Q2 2026

Reported: 2026-08-08

Shares rose 3.6% following Molson Coors' earnings as the company reaffirmed fiscal 2026 guidance and demonstrated resilience amid external pressures including inflation, geopolitical uncertainty, and competitive intensity in key markets.

Key takeaways

Fiscal 2026 guidance was reaffirmed despite volume headwinds attributed to inflation-driven shifts in consumer behavior and geopolitical uncertainty impacting EMEA and APAC regions.
Core U.S. brands like Coors Light and Miller Lite continue to face challenges, prompting new marketing campaigns aimed at reinforcing brand identities and improving consumer engagement.
The launch of Keystone Light Apple generated strong demand, exceeding limited production and driving share gains in the Value segment; Keystone Ice is also being reintroduced.
Above Premium brands showed mixed results: Peroni grew volumes double digits in the U.S., while Blue Moon faced ongoing pressure, though non-alcoholic variants expanded.
Portfolio transformation efforts in beyond beer categories are progressing, with Fever-Tree and Monaco contributing positively to net sales revenue, supporting the Horizon 2030 strategy.

View recap

TBC Bank Group PLC

TBCG.L Q2 2026

Reported: 2026-08-08

TBC shares saw a modest 1.6% increase following earnings, reflecting generally stable performance without a clear positive or negative surprise. Growth in key loan portfolios and dividend payments supported results, while persistent challenges in Uzbekistan’s asset quality and a year-on-year decline in group digital active users temper the outlook.

Key takeaways

Group net profit rose 12% year-on-year to GEL 386 million, with return on equity steady at 23.6%.
Operating income grew 10% year-on-year, supported by a 14% loan portfolio increase in Georgia and stabilization in Uzbekistan.
Cost-to-income ratio improved by nearly 2 percentage points quarter-on-quarter to 38.8%, reflecting disciplined cost management.
Digital monthly active users decreased 6% year-on-year to 7.2 million, despite a 19% increase in Georgian digital MAU, highlighting mixed digital engagement.
Uzbekistan deposit base declined 7% quarter-on-quarter amid liquidity optimization, with continued asset quality pressure and elevated risk costs.

View recap

Taboola.com Ltd. Ordinary Shares

TBLA Q2 2026

Reported: 2026-08-08

Taboola's stock fell 23.6% post-earnings, reflecting investor disappointment with the cautious outlook and deceleration risks highlighted by ongoing headwinds, including the Google policy change and removal of low-quality publishers, which pressured growth and margins despite raised full-year guidance.

Key takeaways

Q2 faced two significant headwinds: a Google policy change deprecating the Explore More product and the removal of low-quality publishers that did not deliver advertiser value.
Raised full-year ex-TAC revenue growth guidance to 9%, but growth acceleration is expected more materially only in late 2026 and into 2027.
Strategic wins include an expanded partnership with a large media company and onboarding FOX News, signaling progress in growing premium publisher relationships and wallet share.
Investments in AI-driven platform Realize and new advertiser tools have early adoption but remain nascent, contributing modestly to current revenue.
Repurchased approximately 9 million shares for $41 million, returning capital while balancing operational challenges.

View recap

Triple Flag Precious Metals Corp.

TFPM Q2 2026

Reported: 2026-08-08

The stock rallied 4.3% after the quarter, driven by better-than-expected organic growth, a major accretive acquisition, and an upward revision to full-year and long-term production guidance.

Key takeaways

Sold nearly 29,000 gold equivalent ounces (GEOs) in Q2, with 59,000 GEOs produced in H1, supporting raised 2026 guidance to 100,000–110,000 GEOs and a 2030 outlook of 150,000–160,000 GEOs.
Adjusted EBITDA reached $117 million, with operating cash flow per share increasing 42% year-over-year to $0.54, highlighting strong margins and cash generation.
Closed a $440 million acquisition of a 5.5% gold stream on Ravenswood Gold Mine, delivering immediate cash flow and adding a large-scale, long-life, low-cost asset.
Strengthened balance sheet with over $1.1 billion liquidity despite acquisition spending, supported by $20 million in opportunistic share repurchases and a 4% dividend increase to an annualized $0.24 per share.
Positive developments at growth projects Hope Bay and Northparkes underpin a robust organic growth pipeline beyond 2030.

View recap

Millicom International Cellular S.A.

TIGO Q2 2026

Reported: 2026-08-08

The shares rose 5.8% as Millicom posted better-than-expected organic revenue growth across mobile and home segments, driven by strong postpaid net additions and solid pricing execution. The market applauded the upgraded free cash flow guidance and improved leverage outlook amid successful integration efforts.

Key takeaways

Service revenue grew 5% organically year-over-year to $2 billion, marking the strongest growth since 2021.
Mobile service revenue increased 6.9% organically to $1.2 billion, supported by 31% growth in postpaid customers and a high pre-to-post migration rate.
Adjusted EBITDA reached a record $1 billion with a healthy margin of 46.3%, despite restructuring costs from the Colombian integration.
Equity free cash flow hit a record $327 million, leading to an upgraded 2026 guidance from $900 million to around $1.1 billion.
The Board approved an additional interim dividend of $1.50 per share, reflecting confidence in cash generation and balance sheet strength.

View recap

Texas Pacific Land Corporation

TPL Q2 2026

Reported: 2026-08-08

TPL shares fell 10.8% following the earnings release, reflecting investor disappointment primarily with the sequential 19% decline in water sales volumes and cautious commentary around weak in-basin natural gas prices impacting development activity, despite strong oil and gas royalty growth.

Key takeaways

Oil and gas royalty production rose 7% sequentially and 20% year-over-year to approximately 39,700 barrels of oil equivalent per day, benefiting from an unhedged royalty position in a strong price environment.
Produced water royalty volumes increased 6% sequentially and 15% year-over-year to 4.9 million barrels per day, supported by demand for both in-basin and out-of-basin pore space.
Water sales volumes dropped 19% sequentially but were up 38% year-over-year, pressured by weak natural gas prices in the Delaware Basin shifting activity away from the area.
Second quarter revenues reached a record $246 million, a 4% sequential gain, driven by diversified streams including a 37% sequential revenue increase from pipeline and wellbore easements in the SLEM segment.
The company is advancing large-scale projects in power generation and data centers and completed a $100 million land acquisition in Texas to support expansion beyond the Permian Basin, though execution timelines remain uncertain.

View recap

Targa Resources Corp.

TRGP Q2 2026

Reported: 2026-08-08

Shares declined 1.2% reflecting investor caution despite record volumes and adjusted EBITDA growth, likely due to modest concerns over ongoing market headwinds and the tempered growth outlook embedded in the cautious tone on natural gas pricing and constrained takeaway capacity.

Key takeaways

Adjusted EBITDA grew 38% year-over-year, with 2026 expected to be near the top end of the company’s prior guidance range, implying nearly $1 billion growth over 2025.
Permian gas volumes set a quarterly record at 7.2 billion cubic feet per day, up 14% year-over-year and 7% sequentially despite ongoing producer shut-ins driven by weak regional pricing.
Marketing businesses outperformed expectations by approximately $250 million in H1 2026, partially offsetting headwinds from shut-in volumes and natural gas takeaway constraints.
Several major Permian processing plants and pipeline projects remain on track for late 2026 and 2027 start-ups, positioning Targa for growth beyond this year.
Although volumes and margins remain strong, challenges such as Waha gas pricing weakness, takeaway constraints, and geopolitical risks continue to weigh on near-term visibility and investor sentiment.

View recap

Sixth Street Specialty Lending, Inc.

TSLX Q2 2026

Reported: 2026-08-08

The stock gained 3.8% as Sixth Street Specialty Lending’s steady net investment income of $0.43 per share and stable net asset value reflected portfolio resilience amid ongoing market uncertainty and gradually improving activity-based fees.

Key takeaways

Net investment income of $0.43 per share delivered an annualized return on equity of 10.6%, with net asset value per share stable at $16.24.
Activity-based fee income contributed $0.08 per share, up sequentially but still below long-term averages; management expects continued improvement in H2.
Portfolio credit quality remained intact with stable nonaccruals and improving interest coverage, supporting durable core earnings.
Investment activity remained consistent at $137 million in fundings despite broader market slowdown; repayments increased 70% sequentially, driving net repayments of $55 million.
Management highlighted a cautious but constructive outlook, noting early signs of increased market transaction activity that could enhance origination and repayment momentum.

View recap

10x Genomics, Inc.

TXG Q2 2026

Reported: 2026-08-08

The 9.6% stock jump reflects strong investor enthusiasm for the Atera platform, which drove robust order flow and broad customer engagement beyond initial expectations.

Key takeaways

Q2 revenue was $151 million, including $1.6 million in non-recurring settlement revenue; organic revenue grew 3% year-over-year to $149 million.
Atera launch generated unusually high early demand, with customers across academia and biopharma adopting the platform for diverse research applications including oncology and neurodegeneration.
Strong growth in Chromium consumable reaction volumes and continued exceptional utilization of the Xenium spatial platform contributed to underlying strength.
Catalyst Research Services, offering sample processing on Atera, has attracted strong interest as a flexible entry point for customers without immediate instrument access.
Acquisition of Proteintech Genomics is expected to enhance Atera’s multi-omics capabilities, particularly in proteomics integration.

View recap

Unity Software Inc.

U Q2 2026

Reported: 2026-08-08

Shares surged 21.2% as Unity far outpaced expectations with a breakout growth acceleration in its Vector advertising platform and improving EBITDA margins, signaling strong momentum in its AI-driven business model.

Key takeaways

Vector advertising revenue grew 23% quarter-over-quarter, nearly double the expected 12-13%, pushing the Strategic Growth segment to 63% year-over-year growth.
Annual run rate for Vector now exceeds $1 billion, achieved two quarters ahead of schedule.
EBITDA margins expanded by 800 basis points year-over-year, approaching 30% for the first time.
Launched Day 28 ROAS product, with campaign spend nearly tripling since Q1 and adoption surpassing 25% of the advertising base.
Introduced runtime data integration into Vector AI models late in Q2, unlocking a new, unique data advantage supporting future growth.

View recap

Unipol Gruppo S.p.A.

UNI.MI Q2 2026

Reported: 2026-08-08

Shares declined 1.6% following the release as investors digested solid earnings growth but appeared cautious on the outlook for business growth, particularly noting some deceleration in the Health segment and the prudent tone around investment income sustainability.

Key takeaways

Net profit exceeded EUR 900 million, up nearly 50% year-on-year, supported by improved technical profitability in Non-Life and Life segments.
Non-Life premiums rose by almost 4%, with the combined ratio improving below 92%, signaling disciplined underwriting despite a challenging nat cat environment.
Life business showed strong premium growth and positive net inflows near EUR 800 million, with improved profitability driven by both technical results and investment income.
Investment yield (excluding one-off SpaceX mark-to-market) stands close to 6%, but for H2 a more conservative 4–5% yield is expected due to the timing of dividend receipts.
Health business growth moderated in H1 versus last year, with management cautiously signaling hopes for reacceleration in H2 driven by new large corporate contracts.

View recap

Vistance Networks, Inc.

VISN Q2 2026

Reported: 2026-08-08

Vistance Networks shares dropped 11.4% after Q2 results as investors reacted to significant margin compression and weak EBITDA performance in the core Aurora segment, despite stable revenue and the recent Ruckus divestiture.

Key takeaways

Aurora Networks reported $319 million in net sales, down 1% year-over-year, indicating slight revenue deceleration.
Adjusted EBITDA plunged 43% year-over-year to $46 million, signaling severe margin pressure in the core business.
Management highlighted a strong balance sheet post-Ruckus sale with $1.75 billion net proceeds and a $5 per share special distribution planned, funded by proceeds.
The company emphasized strategic investments in non-cable product lines such as PON, vBNG, and Security Solutions, which have been underfunded previously.
Despite cash strength and growth initiatives, the steep EBITDA decline and cautious outlook on margin recovery appear to have driven the negative market reaction.

View recap

Vital Farms, Inc.

VITL Q2 2026

Reported: 2026-08-08

Vital Farms reported results in line with the recent challenges detailed last quarter, with the stock essentially unchanged post-earnings as investors weighed a 10.1% decline in net sales amid ongoing supply oversupply and price gap issues. Despite operational adjustments, margin compression and revenue decline kept the market response muted.

Key takeaways

Net sales declined 10.1% year-over-year, reflecting continued impact from industry-wide oversupply and branded competitor price gaps.
Price gaps to branded competitors narrowed modestly from approximately $2.51 to $2.36, which contributed to improved velocity and household acquisition in targeted markets.
Retail dollar share in the shell egg category grew by over 200 basis points year-over-year, signaling resilience within Vital Farms’ premium segment despite category-wide pricing pressure.
Farmer contract amendments are now live, aimed at reducing excess supply and costly breaker sales; management reports oversupply likely peaked in Q2.
Distribution points increased to approximately 148.7 year-to-date, with expectations to reach 170-175 TDPs by Q4 2026, supporting volume growth in H2.

View recap

Verra Mobility Corporation

VRRM Q2 2026

Reported: 2026-08-08

Verra Mobility's shares declined 8.2% after the company’s cautious outlook and ongoing challenges with key metrics weighed on investor sentiment, despite contract renewals with major customers. Investors appeared particularly concerned about deceleration and margin pressures that were not clearly addressed.

Key takeaways

The stock fell sharply by 8.2% in reaction to the earnings report, signaling investor disappointment.
Management highlighted new long-term contracts with Avis Budget Group and Hertz, securing customer relationships but these did not offset broader concerns.
Growth in the government safety segment showed some promise with the potential Los Angeles automated speed safety contract, though it remains under negotiation.
The company acknowledged efforts to realign cost structures and improve operations, suggesting margin pressures persist.
Interim CEO emphasized focusing on customer centricity and technology investment, yet the cautious outlook and deceleration in key metrics overshadowed these strategic priorities.

View recap

Vishay Intertechnology, Inc.

VSH Q2 2026

Reported: 2026-08-08

Vishay’s shares dropped 15.6% after earnings as investors reacted negatively to a clear deceleration in growth momentum and cautious forward indications, despite strong revenue gains. The pronounced correction signals concerns over sustainability of demand and margin pressures not fully addressed by management’s commentary.

Key takeaways

Adjusted Q2 revenue reached $919 million, up 20.5% year-over-year and 9.5% sequentially, driven by broad-based strength across product lines and end markets, notably industrial (up 30.1% YoY).
Book-to-bill ratio stood at 1.32 overall, with semiconductors at 1.23 and passives at 1.40, supporting a backlog of $1.9 billion, or 6.1 months of sales.
About one-third of product SKUs have undergone price increases to offset rising input costs, helping to partially offset margin pressure from materials and logistics inflation.
Demand sustainment appears reliant on extended customer order visibility and inventory build, with some pockets of caution outside AI-related industrial growth; elevated inventory stocking may signal near-term risk.
Management’s optimistic framing contrasts with the sharp market selloff, indicating skepticism on whether Vishay’s “Vishay 3.0” strategy and price actions can sustain momentum amid geopolitical and cost environment challenges.

View recap

Stem, Inc.

VSTM Q2 2026

Reported: 2026-08-08

The stock rallied 14.8% following earnings, driven by meaningful commercial execution and a strengthening balance sheet that exceeded investor expectations.

Key takeaways

Net product revenues of $25.1 million reflected a resumed growth trajectory for AVMAPKI FAKZYNJA CO-PACK, supported by rising physician confidence and increased prescribing in earlier lines of treatment.
The company secured up to $75 million in non-dilutive royalty financing with Oberland Capital, drawing $50 million upfront, alongside a $15 million milestone payment, bolstering liquidity without shareholder dilution.
Encouraging pipeline progress includes completion of enrollment for VS-7375 dose expansion cohorts and FDA fast-track designation for non-small cell lung cancer, with multiple Phase II registration-directed studies underway.
Commercial efforts focus on new patient starts, earlier treatment adoption, and improving patient adherence to therapy, all showing positive momentum during the quarter.
Upcoming data updates on the VS-7375 program in October are expected to be an important catalyst for further validation.

View recap

Warner Bros. Discovery Inc. Series A Common Stock

WBD Q2 2026

Reported: 2026-08-08

The stock rose 3.1% following Q2 results driven by better-than-expected growth and margin expansion in the Streaming segment, which delivered over $3 billion in revenue and significant adjusted EBITDA improvement.

Key takeaways

Streaming revenue surpassed $3 billion for the first time, with subscriber-related revenue growth accelerating 200 basis points sequentially to 10% ex-FX.
Streaming adjusted EBITDA grew more than 60% year-over-year to $512 million, achieving a near 17% margin.
HBO Max’s global audience strength continues, with multiple series averaging at least 25 million global viewers per episode so far in 2026.
Network segment showed resilience despite headwinds, highlighted by significant viewership gains in TNT Sports, MLB, NHL playoffs, CNN, and Discovery’s Shark Week.
Studio performance mixed, with some film underperformance noted, but management emphasized ongoing transformation and diversification to reduce volatility.

View recap

Wix.com Ltd.

WIX Q2 2026

Reported: 2026-08-08

Shares rose 13.6% following better-than-expected demand growth in BASE44 and margin improvement driven by the proprietary Base1 AI platform, which supports a more sustainable profitability profile and underpins increased investment confidence.

Key takeaways

Bookings grew 12% year-over-year and revenue increased 15% year-over-year, supported by strong BASE44 and core Wix business performance.
BASE44 margin improved substantially, moving from roughly 0% earlier in the year to an expected 60% margin in the second half, powered by shifting inference to Base1, Wix’s in-house large language model (LLM).
Self-creators revenue growth accelerated sequentially to 14% year-over-year with stable retention and improving free-to-paid conversion rates.
Partners revenue increased 17% year-over-year, despite organizational realignment including the wind down of InkFrog, which improved GPV mix and monetization.
Management raised its total return on investment (TROI) target for BASE44, signaling confidence in capturing market share in the evolving AI-powered app creation space.

View recap

Chiron Real Estate Inc.

XRN Q2 2026

Reported: 2026-08-08

Chiron’s shares rose modestly by 2.9% following earnings as investors digested ongoing portfolio repositioning and leadership changes alongside steady same-store NOI growth, with no clear catalyst to push the stock above the 3% threshold. While the company highlighted progress on portfolio and leadership fronts, the modest share response reflects cautious investor sentiment awaiting clearer evidence of accelerated growth or margin improvement.

Key takeaways

Same-store NOI increased 1.7% on a normalized basis, consistent with prior guidance.
Executed significant transactions including $200 million gross proceeds from sale of 7 inpatient rehab facilities at a 7.3% exit cap rate.
Under contract to sell Beaumont Surgical Hospital for $49 million, targeting redeployment into higher-return assets like the Pinnacle luxury seniors community.
Strengthened leadership team with four senior hires focused on seniors housing operations, investment, and development expertise.
Balance sheet remains healthy with no debt maturities until 2028 and leverage under 40%.

View recap

Yelp Inc.

YELP Q2 2026

Reported: 2026-08-08

Yelp shares edged down 0.5% following earnings as modest revenue growth and flat Services ad revenue contrasted with ongoing headwinds in RR&O advertising and margin pressure. Investors appear cautious despite accelerated AI-driven revenue streams and product innovations.

Key takeaways

Net revenue grew 1% year-over-year to $376 million, slightly above guidance, but momentum remains subdued amid a difficult economic environment for local businesses.
Services ad revenue was flat at $241 million, reflecting stagnant paid locations and a small increase in ad clicks, while RR&O ad revenue declined 10% to $102 million.
Adjusted EBITDA declined 9% to $91 million, though still above guidance, with margin compression reflecting increased investments in AI initiatives and Hatch team expansion.
Other revenue nearly doubled, rising 98% to $33 million, driven by Hatch, data licensing partnerships (including OpenAI), and new food ordering integrations.
Paid advertising locations decreased 1% to 510,000, and ad clicks fell 5%, signaling persistent challenges in customer engagement despite product enhancements.

View recap

Zoetis Inc.

ZTS Q2 2026

Reported: 2026-08-08

Zoetis shares declined 2.3% following Q2 results that fell short of expectations, primarily due to ongoing deceleration and intensified competitive pressure in the Companion Animal segment and a cautious outlook for the near term.

Key takeaways

Organic operational revenue declined 1% year-over-year; adjusted net income fell 2%.
U.S. revenue dropped 7%, driven by weaker Companion Animal sales, which declined 6%.
International revenue grew 6%, supported by broad-based emerging market strength.
Livestock segment remained a bright spot with 11% revenue growth.
Management announced organizational changes aimed at driving faster decision-making and improved commercial execution amid a challenging environment.

View recap

Earnings Recaps

Allied Gold Corporation

Axcelis Technologies, Inc.

Koninklijke Ahold Delhaize N.V.

Akamai Technologies, Inc.

Albemarle Corporation

APA Corporation

Apple Inc.

Aptiv PLC

Arcturus Therapeutics Holdings Inc.

Arhaus Inc. Class A Common Stock

AerSale Corporation

Allegheny Technologies Incorporated

Atmos Energy Corporation

ATS Corporation

Aura Minerals

Axon Enterprise, Inc.

Becton, Dickinson and Company

BlackSky Technology Inc.

Bloomin' Brands, Inc.

Blend Labs, Inc.

Dutch Bros Inc.

Bentley Systems, Incorporated

Bioventus Inc.

Blackstone Secured Lending Fund

Beyond Meat, Inc.

CAI International, Inc.

Commerzbank AG

Cogent Communications Holdings, Inc.

Century Aluminum Company

IES Holdings, Inc.

Cognex Corporation

Chegg, Inc.

Chime Financial, Inc. Class A Common Stock

Clarus Corporation

Clean Energy Fuels Corp.

Compass Minerals International, Inc.

ConocoPhillips

Copa Holdings, S.A.

CVS Health Corporation

Curtiss-Wright Corporation

Dana Incorporated

Datadog, Inc.

Dragonfly Energy Holdings Corp. Common Stock (NV)

Deutsche Post AG

The Walt Disney Company

Derwent London Plc

Amdocs Limited

Medical Facilities Corporation

eBay Inc.

Okeanis Eco Tankers Corp.

Element Fleet Management Corp.

Entegris, Inc.

Energy Recovery, Inc.

Etsy, Inc.

Expensify Inc. Class A Common Stock

EZCORP, Inc.

Fiserv, Inc.

JFrog Ltd.

Formula One Group

Assicurazioni Generali S.p.A.

GoodRx Holdings, Inc.

Gen Digital Inc. Common Stock

The GEO Group, Inc.

Glencore plc

Genmab A/S

Global Net Lease, Inc.

Gladstone Commercial Corporation

Global Payments Inc.

Green Plains Inc.

The Goodyear Tire & Rubber Company

Gran Tierra Energy Inc.

ZoomInfo Technologies Inc.

GXO Logistics, Inc.

Harvia Oyj

The Honest Company Inc. Common Stock

Heritage Insurance Holdings, Inc.

Installed Building Products, Inc.

Infineon Technologies AG

indie Semiconductor, Inc.